27-12-2019 G U R I Serie generale - n 302 A 2 · 27-12-2019 G AZZETTA U FFICIALE DELLA R EPUBBLICA...
16
— 19 — GAZZETTA UFFICIALE DELLA REPUBBLICA ITALIANA Serie generale - n. 302 27-12-2019 ALLEGATO 2 ATC Principio Attivo AIC Denominazione Confezione Titolare AIC Classe Prezzo (€) PB5 % 2019 N05AX12 ARIPIPRAZOLO 043143027 ABILIFY MAINTENA 1 flaconcino IM 400 mg + 1 flaconcino solv 2 ml rilascio prolungato OTSUKA PHARMACEUT.NETHER.BV H 266,86 x R03AK11 FLUTICASONE PROPIONATO/FORMOTEROLO FUMARATO DIIDRATO 042292019 ABRIFF 120 dosi sosp inal 50 mcg + 5 mcg MUNDIPHARMA PHARMACEUTIC. Srl A 33,00 x R03AK11 FLUTICASONE PROPIONATO/FORMOTEROLO FUMARATO DIIDRATO 042292021 ABRIFF 120 dosi sosp inal 125 mcg + 5 mcg MUNDIPHARMA PHARMACEUTIC. Srl A 50,17 x R03AK11 FLUTICASONE PROPIONATO/FORMOTEROLO FUMARATO DIIDRATO 042292033 ABRIFF 120 dosi sosp inal 250 mcg + 10 mcg MUNDIPHARMA PHARMACEUTIC. Srl A 73,98 x G03FA01 ESTRADIOLO/NORETISTERONE ACETATO 034117010 ACTIVELLE 28 cpr riv 1 mg + 0,5 mg NOVO NORDISK SpA A 9,23 x M04AA03 FEBUXOSTAT 039538018 ADENURIC 28 cpr riv 80 mg A.MENARINI IND.FARM.RIUN.Srl A 19,47 M04AA03 FEBUXOSTAT 039538032 ADENURIC 28 cpr riv 120 mg A.MENARINI IND.FARM.RIUN.Srl A 19,47 L04AD02 TACROLIMUS MONOIDRATO 038218018 ADVAGRAF 30 cps 0,5 mg rilascio prolungato ASTELLAS PHARMA EUROPE B.V. A 46,48 L04AD02 TACROLIMUS MONOIDRATO 038218057 ADVAGRAF 60 cps 1 mg rilascio prolungato ASTELLAS PHARMA EUROPE B.V. A 186,00 L04AD02 TACROLIMUS MONOIDRATO 038218071 ADVAGRAF 30 cps 5 mg rilascio prolungato ASTELLAS PHARMA EUROPE B.V. A 465,00 L04AD02 TACROLIMUS MONOIDRATO 038218119 ADVAGRAF 30 cps 3 mg rilascio prolungato ASTELLAS PHARMA EUROPE B.V. A 278,93 B01AC30 DIPIRIDAMOLO/ACIDO ACETILSALICILICO 033181049 AGGRENOX 60 cps 200 mg + 25 mg rilascio modificato BOEHRINGER INGELHEIM IT.SpA A 21,59 M01AB16 ACECLOFENAC 032773020 AIRTAL 40 cpr riv 100 mg ALMIRALL S.A. A 10,26 M01AB16 ACECLOFENAC 032773032 AIRTAL orale sosp polv 30 bust 100 mg ALMIRALL S.A. A 8,14 x A04AA55 NETUPITANT/PALONOSETRON CLORIDRATO 044201010 AKYNZEO 1 cps 300 mg + 0,5 mg HELSINN BIREX PHARMAC.LTD H 90,46 A16AB05 LARONIDASI 035891011 ALDURAZYME 1 flaconcino EV 5 ml 500 U GENZYME EUROPE B.V. H 665,00 x L01XE36 ALECTINIB 045267010 ALECENSA 56x4 cps 150 mg ROCHE REGISTRATION GMBH H 6.460,00 x N02AB03 FENTANIL 039014028 ALGHEDON 3 cerotti transd 25 mcg/ora ANGELINI SpA A 14,62 x N02AB03 FENTANIL 039014081 ALGHEDON 3 cerotti transd 50 mcg/ora ANGELINI SpA A 23,38 x N02AB03 FENTANIL 039014143 ALGHEDON 3 cerotti transd 75 mcg/ora ANGELINI SpA A 38,20 x N02AB03 FENTANIL 039014206 ALGHEDON 3 cerotti transd 100 mcg/ora ANGELINI SpA A 47,10 x N02AB03 FENTANIL 039014269 ALGHEDON 3 cerotti transd 12 mcg/ora ANGELINI SpA A 5,65 x R03AL03 UMECLIDINIO BROMURO/VILANTEROLO 043438023 ANORO ELLIPTA 30 dosi polv inal 55 mcg + 22 mcg GLAXOSMITHKLINE (IRELAND) LTD A 63,50 x A10AB06 INSULINA GLULISINA 036684013 APIDRA 1 flaconcino SC 10 ml 100 UI/ml SANOFI AVENTIS DEUTSCHL.GMBH A 32,93 x A10AB06 INSULINA GLULISINA 036684088 APIDRA 5 cartucce SC 3 ml 300 UI SANOFI AVENTIS DEUTSCHL.GMBH A 49,39 x A10AB06 INSULINA GLULISINA 036684328 APIDRA solostar 5 penne preriempite SC 100 U/ml 3 ml SANOFI AVENTIS DEUTSCHL.GMBH A 49,39 x B01AX05 FONDAPARINUX SODICO 035606033 ARIXTRA 10 siringhe SC 2,5 mg 0,5 ml ASPEN PHARMA TRADING LIMITED A 67,45 x
Transcript of 27-12-2019 G U R I Serie generale - n 302 A 2 · 27-12-2019 G AZZETTA U FFICIALE DELLA R EPUBBLICA...
— 19 —
GAZZETTA UFFICIALE DELLA REPUBBLICA ITALIANA Serie generale - n. 30227-12-2019
ALLEGATO 2
ATC
Prin
cipi
o At
tivo
AIC
Den
omin
azio
ne
Conf
ezio
ne
Tito
lare
AIC
Cl
asse
Pr
ezzo
(€)
PB5
%
2019
N05
AX12
AR
IPIP
RAZO
LO
0431
4302
7 AB
ILIF
Y M
AIN
TEN
A 1
flaco
ncin
o IM
400
mg
+ 1
flaco
ncin
o so
lv 2
ml r
ilasc
io
prol
unga
to
OTS
UKA
PH
ARM
ACEU
T.N
ETHE
R.BV
H 26
6,86
x
R03A
K11
FLU
TICA
SON
E PR
OPI
ON
ATO
/FO
RMO
TERO
LO F
UM
ARAT
O D
IIDRA
TO
0422
9201
9 AB
RIFF
12
0 do
si so
sp in
al 5
0 m
cg +
5 m
cg
MU
NDI
PHAR
MA
PHAR
MAC
EUTI
C. S
rl
A 33
,00
x
R03A
K11
FLU
TICA
SON
E PR
OPI
ON
ATO
/FO
RMO
TERO
LO F
UM
ARAT
O D
IIDRA
TO
0422
9202
1 AB
RIFF
12
0 do
si so
sp in
al 1
25 m
cg +
5 m
cg
MU
NDI
PHAR
MA
PHAR
MAC
EUTI
C. S
rl
A 50
,17
x
R03A
K11
FLU
TICA
SON
E PR
OPI
ON
ATO
/FO
RMO
TERO
LO F
UM
ARAT
O D
IIDRA
TO
0422
9203
3 AB
RIFF
12
0 do
si so
sp in
al 2
50 m
cg +
10
mcg
M
UN
DIPH
ARM
A PH
ARM
ACEU
TIC.
Srl
A
73,9
8
x
G03
FA01
ES
TRAD
IOLO
/NO
RETI
STER
ON
E AC
ETAT
O
0341
1701
0 AC
TIVE
LLE
28 c
pr ri
v 1
mg
+ 0,
5 m
g N
OVO
NO
RDIS
K Sp
A
A 9,
23
x
M04
AA03
FE
BUXO
STAT
03
9538
018
ADEN
URI
C 28
cpr
riv
80 m
g A.
MEN
ARIN
I IN
D.FA
RM.R
IUN
.Srl
A 19
,47
M04
AA03
FE
BUXO
STAT
03
9538
032
ADEN
URI
C 28
cpr
riv
120
mg
A.M
ENAR
INI I
ND.
FARM
.RIU
N.S
rl A
19,4
7
L04A
D02
TACR
OLI
MU
S M
ON
OID
RATO
03
8218
018
ADVA
GRA
F 30
cps
0,5
mg
rilas
cio
prol
unga
to
ASTE
LLAS
PHA
RMA
EURO
PE
B.V.
A 46
,48
L04A
D02
TACR
OLI
MU
S M
ON
OID
RATO
03
8218
057
ADVA
GRA
F 60
cps
1 m
g ril
asci
o pr
olun
gato
AS
TELL
AS P
HARM
A EU
ROPE
B.
V.
A
186,
00
L04A
D02
TACR
OLI
MU
S M
ON
OID
RATO
03
8218
071
ADVA
GRA
F 30
cps
5 m
g ril
asci
o pr
olun
gato
AS
TELL
AS P
HARM
A EU
ROPE
B.
V.
A
465,
00
L04A
D02
TACR
OLI
MU
S M
ON
OID
RATO
03
8218
119
ADVA
GRA
F 30
cps
3 m
g ril
asci
o pr
olun
gato
AS
TELL
AS P
HARM
A EU
ROPE
B.
V.
A
278,
93
B01A
C30
DIPI
RIDA
MO
LO/A
CIDO
ACE
TILS
ALIC
ILIC
O
0331
8104
9 AG
GRE
NO
X 60
cps
200
mg
+ 25
mg
rilas
cio
mod
ifica
to
BOEH
RIN
GER
ING
ELHE
IM IT
.SpA
A
21,5
9
M01
AB16
AC
ECLO
FEN
AC
0327
7302
0 AI
RTAL
40
cpr
riv
100
mg
ALM
IRAL
L S.
A.
A
10,2
6
M01
AB16
AC
ECLO
FEN
AC
0327
7303
2 AI
RTAL
or
ale
sosp
pol
v 30
bus
t 100
mg
ALM
IRAL
L S.
A.
A
8,14
x
A04A
A55
NET
UPI
TAN
T/PA
LON
OSE
TRO
N C
LORI
DRAT
O
0442
0101
0 AK
YNZE
O
1 cp
s 30
0 m
g +
0,5
mg
HELS
INN
BIR
EX P
HARM
AC.L
TD
H
90,4
6
A16A
B05
LARO
NID
ASI
0358
9101
1 AL
DURA
ZYM
E 1
flaco
ncin
o EV
5 m
l 500
U
GEN
ZYM
E EU
ROPE
B.V
.
H
665,
00
x
L01X
E36
ALEC
TIN
IB
0452
6701
0 AL
ECEN
SA
56x4
cps
150
mg
ROCH
E RE
GIS
TRAT
ION
GM
BH
H 6.
460,
00
x
N02
AB03
FE
NTA
NIL
03
9014
028
ALG
HEDO
N
3 ce
rott
i tra
nsd
25 m
cg/o
ra
ANG
ELIN
I SpA
A
14,6
2
x
N02
AB03
FE
NTA
NIL
03
9014
081
ALG
HEDO
N
3 ce
rott
i tra
nsd
50 m
cg/o
ra
ANG
ELIN
I SpA
A
23,3
8
x
N02
AB03
FE
NTA
NIL
03
9014
143
ALG
HEDO
N
3 ce
rott
i tra
nsd
75 m
cg/o
ra
ANG
ELIN
I SpA
A
38,2
0
x
N02
AB03
FE
NTA
NIL
03
9014
206
ALG
HEDO
N
3 ce
rott
i tra
nsd
100
mcg
/ora
AN
GEL
INI S
pA
A 47
,10
x
N02
AB03
FE
NTA
NIL
03
9014
269
ALG
HEDO
N
3 ce
rott
i tra
nsd
12 m
cg/o
ra
ANG
ELIN
I SpA
A
5,65
x
R03A
L03
UM
ECLI
DIN
IO B
ROM
URO
/VIL
ANTE
ROLO
04
3438
023
ANO
RO E
LLIP
TA
30 d
osi p
olv
inal
55
mcg
+ 2
2 m
cg
GLA
XOSM
ITHK
LIN
E (IR
ELAN
D)
LTD
A
63,5
0
x
A10A
B06
INSU
LIN
A G
LULI
SIN
A 03
6684
013
APID
RA
1 fla
conc
ino
SC 1
0 m
l 100
UI/
ml
SAN
OFI
AVE
NTI
S DE
UTS
CHL.
GM
BH
A 32
,93
x
A10A
B06
INSU
LIN
A G
LULI
SIN
A 03
6684
088
APID
RA
5 ca
rtuc
ce S
C 3
ml 3
00 U
I SA
NO
FI A
VEN
TIS
DEU
TSCH
L.G
MBH
A
49,3
9
x
A10A
B06
INSU
LIN
A G
LULI
SIN
A 03
6684
328
APID
RA
solo
star
5 p
enne
pre
riem
pite
SC
100
U/m
l 3 m
l SA
NO
FI A
VEN
TIS
DEU
TSCH
L.G
MBH
A
49,3
9
x
B01A
X05
FON
DAPA
RIN
UX
SODI
CO
0356
0603
3 AR
IXTR
A 10
siri
nghe
SC
2,5
mg
0,5
ml
ASPE
N P
HARM
A TR
ADIN
G
LIM
ITED
A
67,4
5
x
— 20 —
GAZZETTA UFFICIALE DELLA REPUBBLICA ITALIANA Serie generale - n. 30227-12-2019
ATC
Prin
cipi
o At
tivo
AIC
Den
omin
azio
ne
Conf
ezio
ne
Tito
lare
AIC
Cl
asse
Pr
ezzo
(€)
PB5
%
2019
B01A
X05
FON
DAPA
RIN
UX
SODI
CO
0356
0607
2 AR
IXTR
A 10
siri
nghe
SC
1,5
mg
0,3
ml
ASPE
N P
HARM
A TR
ADIN
G
LIM
ITED
A
40,4
7
x
B01A
X05
FON
DAPA
RIN
UX
SODI
CO
0356
0611
0 AR
IXTR
A 10
siri
nghe
SC
5 m
g 0,
4 m
l AS
PEN
PHA
RMA
TRAD
ING
LI
MIT
ED
A 13
8,04
x
B01A
X05
FON
DAPA
RIN
UX
SODI
CO
0356
0614
6 AR
IXTR
A 10
siri
nghe
SC
7,5
mg
0,6
ml
ASPE
N P
HARM
A TR
ADIN
G
LIM
ITED
A
207,
01
x
B01A
X05
FON
DAPA
RIN
UX
SODI
CO
0356
0617
3 AR
IXTR
A 10
siri
nghe
SC
10 m
g 0,
8 m
l AS
PEN
PHA
RMA
TRAD
ING
LI
MIT
ED
A 20
7,01
x
R03A
K07
BUDE
SON
IDE/
FORM
OTE
ROLO
FU
MAR
ATO
DIID
RATO
03
5362
060
ASSI
EME
polv
inal
120
dos
i 160
mcg
+ 4
,5 m
cg tu
rboh
aler
SI
MES
A Sp
A
A 62
,41
x
R03A
K07
BUDE
SON
IDE/
FORM
OTE
ROLO
FU
MAR
ATO
DIID
RATO
03
5363
062
ASSI
EME
MIT
E po
lv in
al 1
20 d
osi 8
0 m
cg +
4,5
mcg
SI
MES
A Sp
A
A 49
,42
x
G03
GA0
5 FO
LLIT
ROPI
NA
ALFA
DA
DNA
RICO
MBI
NAN
TE
0433
6401
3 BE
MFO
LA
1 ca
rtuc
cia
in p
enna
pre
riem
p SC
75
UI/
0,12
5 m
l + a
go
GED
EON
RIC
HTER
PLC
A
32,4
8
x
G03
GA0
5 FO
LLIT
ROPI
NA
ALFA
DA
DNA
RICO
MBI
NAN
TE
0433
6402
5 BE
MFO
LA
1 ca
rtuc
cia
in p
enna
pre
riem
p SC
150
UI/
0,25
ml +
ago
G
EDEO
N R
ICHT
ER P
LC
A 64
,13
x
G03
GA0
5 FO
LLIT
ROPI
NA
ALFA
DA
DNA
RICO
MBI
NAN
TE
0433
6403
7 BE
MFO
LA
1 ca
rtuc
cia
in p
enna
pre
riem
p SC
225
UI/
0,37
5 m
l + a
go
GED
EON
RIC
HTER
PLC
A
95,0
0
x
G03
GA0
5 FO
LLIT
ROPI
NA
ALFA
DA
DNA
RICO
MBI
NAN
TE
0433
6404
9 BE
MFO
LA
1 ca
rtuc
cia
in p
enna
pre
riem
p SC
300
UI/
0,50
ml +
ago
G
EDEO
N R
ICHT
ER P
LC
A 12
5,06
x
G03
GA0
5 FO
LLIT
ROPI
NA
ALFA
DA
DNA
RICO
MBI
NAN
TE
0433
6405
2 BE
MFO
LA
1 ca
rtuc
cia
in p
enna
pre
riem
p SC
450
UI/
0,75
ml +
ago
G
EDEO
N R
ICHT
ER P
LC
A 18
5,15
x
G03
GA0
5 FO
LLIT
ROPI
NA
ALFA
DA
DNA
RICO
MBI
NAN
TE
0433
6406
4 BE
MFO
LA
5 ca
rtuc
ce in
pen
ne p
rerie
mp
SC 7
5 U
I/0,
125
ml +
5 a
ghi
GED
EON
RIC
HTER
PLC
A
162,
41
x
G03
GA0
5 FO
LLIT
ROPI
NA
ALFA
DA
DNA
RICO
MBI
NAN
TE
0433
6408
8 BE
MFO
LA
5 ca
rtuc
ce in
pen
ne p
rerie
mp
SC 1
50 U
I/0,
125
ml +
5
aghi
G
EDEO
N R
ICHT
ER P
LC
A 32
0,68
x
G03
GA0
5 FO
LLIT
ROPI
NA
ALFA
DA
DNA
RICO
MBI
NAN
TE
0433
6410
2 BE
MFO
LA
5 ca
rtuc
ce in
pen
ne p
rerie
mp
SC 2
25 U
I/3,
75 m
l + 5
agh
i G
EDEO
N R
ICHT
ER P
LC
A 47
5,00
x
G03
GA0
5 FO
LLIT
ROPI
NA
ALFA
DA
DNA
RICO
MBI
NAN
TE
0433
6412
6 BE
MFO
LA
5 ca
rtuc
ce in
pen
ne p
rerie
mp
SC 3
00 U
I/0,
50 m
l + 5
agh
i G
EDEO
N R
ICHT
ER P
LC
A 62
5,32
x
G03
GA0
5 FO
LLIT
ROPI
NA
ALFA
DA
DNA
RICO
MBI
NAN
TE
0433
6414
0 BE
MFO
LA
5 ca
rtuc
ce in
pen
ne p
rerie
mp
SC 4
50 U
I/0,
75 m
l + 5
agh
i G
EDEO
N R
ICHT
ER P
LC
A 92
5,76
x
L04A
A26
BELI
MU
MAB
04
1381
017
BEN
LYST
A 1
flaco
ncin
o EV
120
mg
GLA
XOSM
ITHK
LIN
E (IR
ELAN
D)
LTD
H
138,
91
x
L04A
A26
BELI
MU
MAB
04
1381
029
BEN
LYST
A 1
flaco
ncin
o EV
400
mg
GLA
XOSM
ITHK
LIN
E (IR
ELAN
D)
LTD
H
463,
03
x
L04A
A26
BELI
MU
MAB
04
1381
043
BEN
LYST
A 4
penn
e pr
erie
mpi
te S
C 20
0 m
g G
LAXO
SMIT
HKLI
NE
(IREL
AND)
LT
D
H 92
6,06
x
M05
BA04
AC
IDO
ALE
NDR
ON
ICO
SAL
E SO
DICO
TRI
IDRA
TO
0402
4601
1 BI
NO
STO
4
cpr e
ff 70
mg
ABIO
GEN
PHA
RMA
SpA
A 16
,18
x
M05
BA04
AC
IDO
ALE
NDR
ON
ICO
SAL
E SO
DICO
TRI
IDRA
TO
0406
2203
3 BO
NAS
OL
oral
e so
luz
4 fla
coni
70
mg
100
ml
BRU
NO
FAR
MAC
EUTI
CI S
pA
A 16
,18
x
R03B
B05
ACLI
DIN
IO B
ROM
URO
04
2470
029
BRET
ARIS
GEN
UAI
R 1
flaco
ne 6
0 do
si po
lv in
al 3
22 m
cg
ASTR
AZEN
ECA
AB
A
48,2
6
x
B01A
C24
TICA
GRE
LOR
0405
4604
4 BR
ILIQ
UE
56 c
pr ri
v 90
mg
ASTR
AZEN
ECA
AB
A
106,
68
x
B01A
C24
TICA
GRE
LOR
0405
4608
3 BR
ILIQ
UE
56 c
pr ri
v 60
mg
conf
ezio
ne c
alen
dariz
zata
AS
TRAZ
ENEC
A AB
A 10
6,68
x
R03A
L05
ACLI
DIN
IO B
ROM
URO
/FO
RMO
TERO
LO F
UM
ARAT
O D
IIDRA
TO
0437
7301
1 BR
IMIC
A G
ENU
AIR
1 in
alat
ore
60 d
osi p
olv
inal
340
mcg
+ 1
2 m
cg
ASTR
AZEN
ECA
AB
A
63,5
0
x
J05A
B15
BRIV
UDI
NA
0357
2001
0 BR
IVIR
AC
7 cp
r 125
mg
LABO
RATO
RI G
UID
OTT
I SpA
A
95,9
3
x
A16A
A01
LEVO
CARN
ITIN
A 01
8610
079
CARN
ITEN
E or
ale
solu
z 10
flac
onci
ni 2
g
ALFA
SIG
MA
SpA
A 15
,63
x
— 21 —
GAZZETTA UFFICIALE DELLA REPUBBLICA ITALIANA Serie generale - n. 30227-12-2019
ATC
Prin
cipi
o At
tivo
AIC
Den
omin
azio
ne
Conf
ezio
ne
Tito
lare
AIC
Cl
asse
Pr
ezzo
(€)
PB5
%
2019
A16A
X10
ELIG
LUST
AT T
ARTR
ATO
04
3869
015
CERD
ELG
A 56
cps
84
mg
GEN
ZYM
E EU
ROPE
B.V
.
A
32.6
98,9
5
x
L04A
A18
EVER
OLI
MU
S 03
6373
025
CERT
ICAN
60
cpr
0,2
5 m
g N
OVA
RTIS
FAR
MA
SpA
A
165,
89
x
L04A
A18
EVER
OLI
MU
S 03
6373
102
CERT
ICAN
60
cpr
0,7
5 m
g N
OVA
RTIS
FAR
MA
SpA
A
497,
65
x
L04A
A18
EVER
OLI
MU
S 03
6373
227
CERT
ICAN
60
cpr
dis
pers
0,2
5 m
g N
OVA
RTIS
FAR
MA
SpA
A
165,
89
x
J01M
A17
PRU
LIFL
OXA
CIN
A 03
5679
012
CHIN
OPL
US
1 cp
r riv
600
mg
SPA
(SO
C.PR
O.A
NTI
BIO
TICI
) SpA
A
8,66
x
J01M
A17
PRU
LIFL
OXA
CIN
A 03
5679
036
CHIN
OPL
US
5 cp
r riv
600
mg
SPA
(SO
C.PR
O.A
NTI
BIO
TICI
) SpA
A
20,5
7
x
G03
CA04
ES
TRIO
LO
0258
5102
7 CO
LPO
GYN
cr
ema
vag
30 g
+ 6
app
lic
ANG
ELIN
I SpA
A
3,
18
G03
CA04
ES
TRIO
LO
0258
5106
6 CO
LPO
GYN
20
ov
vag
1 m
g AN
GEL
INI S
pA
A 7,
85
x
G03
XC02
BA
ZEDO
XIFE
NE
ACET
ATO
03
9364
017
CON
BRIZ
A 28
cpr
riv
20 m
g PF
IZER
EU
ROPE
MA
EEIG
A 34
,68
x
V04C
D01
M
ETIR
APO
NE
0430
9401
0 CO
RMET
O
50 c
ps m
olli
250
mg
flaco
ne
LABO
RATO
IRE
HRA
PHAR
MA
A
381,
78
x
C09B
X02
BISO
PRO
LOLO
FU
MAR
ATO
/PER
IND
OPR
IL A
RGIN
INA
0442
5602
8 CO
SYRE
L 30
cpr
riv
5 m
g +
5 m
g fla
cone
LE
S LA
BORA
TOIR
ES S
ERVI
ER
A 9,
96
x
C09B
X02
BISO
PRO
LOLO
FU
MAR
ATO
/PER
IND
OPR
IL A
RGIN
INA
0442
5605
5 CO
SYRE
L 30
cpr
riv
5 m
g +
10 m
g fla
cone
LE
S LA
BORA
TOIR
ES S
ERVI
ER
A 9,
96
x
C09B
X02
BISO
PRO
LOLO
FU
MAR
ATO
/PER
IND
OPR
IL A
RGIN
INA
0442
5608
1 CO
SYRE
L 30
cpr
riv
10 m
g +
5 m
g fla
cone
LE
S LA
BORA
TOIR
ES S
ERVI
ER
A 10
,35
x
C09B
X02
BISO
PRO
LOLO
FU
MAR
ATO
/PER
IND
OPR
IL A
RGIN
INA
0442
5611
7 CO
SYRE
L 30
cpr
riv
10 m
g +
10 m
g fla
cone
LE
S LA
BORA
TOIR
ES S
ERVI
ER
A 10
,35
x
A09A
A02
PAN
CREL
IPAS
I 02
9018
064
CREO
N 1
0.00
0UI
100
cps
gast
rore
s 15
0 m
g ril
asci
o m
odifi
cato
M
YLAN
ITAL
IA S
rl
A 17
,31
x
L01X
C21
RAM
UCI
RUM
AB
0437
9701
2 CY
RAM
ZA
1 fla
conc
ino
EV 1
0 m
l 10
mg/
ml
ELI L
ILLY
NED
ERLA
ND
BV
H 57
0,00
x
L01X
C21
RAM
UCI
RUM
AB
0437
9703
6 CY
RAM
ZA
1 fla
conc
ino
EV 5
0 m
l 10
mg/
ml
ELI L
ILLY
NED
ERLA
ND
BV
H 2.
850,
00
x
R05D
B27
LEVO
DRO
PRO
PIZI
NA
0427
4301
7 DA
NKA
TO
SSE
oral
e gt
t 30
ml 6
0 m
g/m
l AN
GEL
INI S
pA
A 9,
77
x
R03D
X07
ROFL
UM
ILAS
T 04
0107
029
DAXA
S 30
cpr
riv
500
mcg
AS
TRAZ
ENEC
A AB
A 65
,85
x
J04A
K06
DELA
MAN
ID
0433
6704
6 DE
LTYB
A 48
cpr
riv
50 m
g O
TSU
KA N
OVE
L PR
ODU
CTS
GM
BH
H
1.38
5,67
x
N02
AJ17
O
XICO
DO
NE
CLO
RIDR
ATO
/PAR
ACET
AMO
LO
0353
1302
8 DE
PALG
OS
28 c
pr ri
v 5
mg
+ 32
5 m
g M
OLT
ENI &
C. F
.LLI
ALI
TTI S
pA
A 15
,30
x
N02
AJ17
O
XICO
DO
NE
CLO
RIDR
ATO
/PAR
ACET
AMO
LO
0353
1305
5 DE
PALG
OS
28 c
pr ri
v 10
mg
+ 32
5 m
g M
OLT
ENI &
C. F
.LLI
ALI
TTI S
pA
A 15
,30
x
N02
AJ17
O
XICO
DO
NE
CLO
RIDR
ATO
/PAR
ACET
AMO
LO
0353
1308
1 DE
PALG
OS
28 c
pr ri
v 20
mg
+ 32
5 m
g M
OLT
ENI &
C. F
.LLI
ALI
TTI S
pA
A 15
,30
x
N03
AG01
M
AGN
ESIO
VAL
PRO
ATO
02
7107
010
DEPA
MAG
40
cpr
gas
tror
es 2
00 m
g AL
FASI
GM
A Sp
A
A
4,
60
N03
AG01
M
AGN
ESIO
VAL
PRO
ATO
02
7107
022
DEPA
MAG
40
cpr
gas
tror
es 5
00 m
g AL
FASI
GM
A Sp
A
A
7,93
N03
AG01
M
AGN
ESIO
VAL
PRO
ATO
02
7107
034
DEPA
MAG
or
ale
solu
z 10
0 m
l 10%
AL
FASI
GM
A Sp
A
A
5,51
N01
AH03
SU
FEN
TAN
IL C
ITRA
TO
0363
2301
8 DI
SUFE
N
5 fia
le E
V 1
ml 5
0 m
cg/m
l AN
GEL
INI S
pA
H 4,
70
x
N01
AH03
SU
FEN
TAN
IL C
ITRA
TO
0363
2303
2 DI
SUFE
N
5 fia
le 5
ml 5
0 m
cg/m
l AN
GEL
INI S
pA
H 23
,09
x
— 22 —
GAZZETTA UFFICIALE DELLA REPUBBLICA ITALIANA Serie generale - n. 30227-12-2019
ATC
Prin
cipi
o At
tivo
AIC
Den
omin
azio
ne
Conf
ezio
ne
Tito
lare
AIC
Cl
asse
Pr
ezzo
(€)
PB5
%
2019
R03A
L05
ACLI
DIN
IO B
ROM
URO
/FO
RMO
TERO
LO F
UM
ARAT
O D
IIDRA
TO
0437
7701
0 DU
AKLI
R G
ENU
AIR
1 in
alat
ore
60 d
osi p
olv
inal
340
mcg
+ 1
2 m
cg
ASTR
AZEN
ECA
AB
A
63,5
0
x
B01A
C30
CLO
PID
OG
REL
IDRO
GEN
OSO
LFAT
O/A
CIDO
ACE
TILS
ALIC
ILIC
O
0397
6309
1 DU
OPL
AVIN
28
cpr
riv
75 m
g +
100
mg
SAN
OFI
-AVE
NTI
S G
ROU
PE
A
24,2
1
x
B01A
C30
CLO
PID
OG
REL
IDRO
GEN
OSO
LFAT
O/A
CIDO
ACE
TILS
ALIC
ILIC
O
0447
2301
7 DU
OPL
AVIN
28
cpr
riv
75 m
g +
100
mg
GEN
ERAL
PHA
RMA
SOLU
TIO
NS
SpA
A
24
,21
x
B01A
C30
CLO
PID
OG
REL
IDRO
GEN
OSO
LFAT
O/A
CIDO
ACE
TILS
ALIC
ILIC
O
0465
9001
6 DU
OPL
AVIN
28
cpr
riv
75 m
g +
100
mg
MED
IWIN
LIM
ITED
A
24,2
1
x
R03A
K07
BUDE
SON
IDE/
FORM
OTE
ROLO
FU
MAR
ATO
DIID
RATO
04
3366
018
DUO
RESP
SP
IRO
MAX
po
lv in
al 1
20 d
osi 1
60 m
cg +
4,5
mcg
TE
VA P
HARM
A B.
V.
A 45
,46
R03A
K07
BUDE
SON
IDE/
FORM
OTE
ROLO
FU
MAR
ATO
DIID
RATO
04
3366
044
DUO
RESP
SP
IRO
MAX
po
lv in
al 6
0 do
si 32
0 m
cg +
9 m
cg
TEVA
PHA
RMA
B.V.
A
45,4
6
M03
AX01
TO
SSIN
A BO
TULI
NIC
A DI
CLO
STRI
DIU
M B
OTU
LIN
UM
TIP
O A
02
8362
022
DYSP
ORT
2
fiale
IM S
C 50
0 U
IP
SEN
SpA
H 44
4,05
A10B
D07
SITA
GLI
PTIN
FO
SFAT
O M
ON
OID
RATO
/MET
FORM
INA
CLO
RIDR
ATO
03
8773
038
EFFI
CIB
56 c
pr ri
v 50
mg
+ 85
0 m
g M
ERCK
SHA
RP &
DO
HME
BV
A 62
,34
x
A10B
D07
SITA
GLI
PTIN
FO
SFAT
O M
ON
OID
RATO
/MET
FORM
INA
CLO
RIDR
ATO
03
8773
103
EFFI
CIB
56 c
pr ri
v 50
mg
+ 1.
000
mg
MER
CK S
HARP
& D
OHM
E BV
A
62,3
4
x
R03B
B05
ACLI
DIN
IO B
ROM
URO
04
2471
021
EKLI
RA G
ENU
AIR
1 in
alat
ore
60 d
osi p
olv
inal
322
mcg
AS
TRAZ
ENEC
A AB
A 48
,26
x
N06
AX12
BU
PRO
PIO
NE
CLO
RIDR
ATO
03
7697
051
ELO
NTR
IL
30 c
pr 3
00 m
g ril
asci
o m
odifi
cato
flac
one
GLA
XOSM
ITHK
LIN
E Sp
A
A
41,0
4
x
C09D
X04
SACU
BITR
IL/V
ALSA
RTAN
CO
MPL
ESSO
DI S
ALE
SODI
CO
0445
5801
7 EN
TRES
TO
28 c
pr ri
v 24
mg
+ 26
mg
NO
VART
IS E
URO
PHAR
M L
TD
A 10
0,98
x
C09D
X04
SACU
BITR
IL/V
ALSA
RTAN
CO
MPL
ESSO
DI S
ALE
SODI
CO
0445
5802
9 EN
TRES
TO
28 c
pr ri
v 49
mg
+ 51
mg
NO
VART
IS E
URO
PHAR
M L
TD
A 10
0,98
x
C09D
X04
SACU
BITR
IL/V
ALSA
RTAN
CO
MPL
ESSO
DI S
ALE
SODI
CO
0445
5803
1 EN
TRES
TO
56 c
pr ri
v 49
mg
+ 51
mg
NO
VART
IS E
URO
PHAR
M L
TD
A 20
1,94
x
C09D
X04
SACU
BITR
IL/V
ALSA
RTAN
CO
MPL
ESSO
DI S
ALE
SODI
CO
0445
5806
8 EN
TRES
TO
56 c
pr ri
v 97
mg
+ 10
3 m
g N
OVA
RTIS
EU
ROPH
ARM
LTD
A
201,
94
x
N06
BA04
M
ETIL
FEN
IDAT
O C
LORI
DRAT
O
0418
8904
1 EQ
UAS
YM
30 c
ps 1
0 m
g ril
asci
o m
odifi
cato
SH
IRE
PHAR
MAC
EUT.
IREL
AND
LTD
A
18,8
8
x
N06
BA04
M
ETIL
FEN
IDAT
O C
LORI
DRAT
O
0418
8910
4 EQ
UAS
YM
30 c
ps 2
0 m
g ril
asci
o m
odifi
cato
SH
IRE
PHAR
MAC
EUT.
IREL
AND
LTD
A
42,5
2
x
N06
BA04
M
ETIL
FEN
IDAT
O C
LORI
DRAT
O
0418
8915
5 EQ
UAS
YM
30 c
ps 3
0 m
g ril
asci
o m
odifi
cato
SH
IRE
PHAR
MAC
EUT.
IREL
AND
LTD
A
55,7
1
x
C01C
A24
ADRE
NAL
INA
0424
1601
4 FA
STJE
KT
1 pe
nna
prer
iem
pita
150
mcg
M
EDA
PHAR
MA
SpA
H
47,2
0
x
C01C
A24
ADRE
NAL
INA
0424
1603
8 FA
STJE
KT
1 pe
nna
prer
iem
pita
300
mcg
M
EDA
PHAR
MA
SpA
H
47,2
0
x
G03
FA11
ES
TRAD
IOLO
/LEV
ON
ORG
ESTR
EL
0364
8901
9 FE
MIT
Y 4
cero
tti t
rans
d 50
mcg
/die
+ 7
mcg
/die
TH
ERAM
EX IR
ELAN
D LI
MIT
ED
A 9,
36
G03
FB08
ES
TRAD
IOLO
/DID
ROG
ESTE
RON
E 03
3639
055
FEM
OST
ON
1/1
0 14
cpr
riv
bian
che
+ 14
cpr
riv
grig
ie
MYL
AN IR
E HE
ALTH
CARE
LI
MIT
ED
A 9,
23
x
G03
FA14
ES
TRAD
IOLO
/DID
ROG
ESTE
RON
E 03
3639
081
FEM
OST
ON
1/5
CO
NTI
28
cpr
riv
1 m
g +
5 m
g M
YLAN
IRE
HEAL
THCA
RE
LIM
ITED
A
9,23
x
G03
FB08
ES
TRAD
IOLO
/DID
ROG
ESTE
RON
E 03
3639
016
FEM
OST
ON
2/1
0 14
cpr
riv
ross
e +
14 c
pr ri
v gi
alle
M
YLAN
IRE
HEAL
THCA
RE
LIM
ITED
A
9,23
x
M01
AE14
DE
XIBU
PRO
FEN
E 03
5512
045
FEN
EXTR
A 30
cpr
riv
400
mg
BRU
NO
FAR
MAC
EUTI
CI S
pA
A 7,
42
x
M01
AE14
DE
XIBU
PRO
FEN
E 03
5512
072
FEN
EXTR
A or
ale
grat
30
bust
300
mg
BRU
NO
FAR
MAC
EUTI
CI S
pA
A 5,
56
x
M01
AE14
DE
XIBU
PRO
FEN
E 03
5512
084
FEN
EXTR
A or
ale
grat
30
bust
400
mg
BRU
NO
FAR
MAC
EUTI
CI S
pA
A 7,
42
x
— 23 —
GAZZETTA UFFICIALE DELLA REPUBBLICA ITALIANA Serie generale - n. 30227-12-2019
ATC
Prin
cipi
o At
tivo
AIC
Den
omin
azio
ne
Conf
ezio
ne
Tito
lare
AIC
Cl
asse
Pr
ezzo
(€)
PB5
%
2019
A10A
B05
INSU
LIN
A AS
PART
04
5249
051
FIAS
P fle
xtou
ch 5
pen
ne 1
00 U
/ml 3
ml
NO
VO N
ORD
ISK
A/S
A
52,3
6
x
A10A
B05
INSU
LIN
A AS
PART
04
5249
101
FIAS
P pe
nfill
5 c
artu
cce
100
U/m
l 3 m
l N
OVO
NO
RDIS
K A/
S
A 52
,36
x
D07A
C17
FLU
TICA
SON
E PR
OPI
ON
ATO
02
9014
038
FLIX
ODE
RM
ung
derm
30
g 0,
005%
G
LAXO
SMIT
HKLI
NE
SpA
A 6,
17
x
R03A
K11
FLU
TICA
SON
E PR
OPI
ON
ATO
/FO
RMO
TERO
LO F
UM
ARAT
O D
IIDRA
TO
0422
9401
3 FL
UTI
FORM
O
120
dosi
sosp
inal
50
mcg
+ 5
mcg
M
UN
DIPH
ARM
A PH
ARM
ACEU
TIC.
Srl
A
33,0
0
x
R03A
K11
FLU
TICA
SON
E PR
OPI
ON
ATO
/FO
RMO
TERO
LO F
UM
ARAT
O D
IIDRA
TO
0422
9402
5 FL
UTI
FORM
O
120
dosi
sosp
inal
125
mcg
+ 5
mcg
M
UN
DIPH
ARM
A PH
ARM
ACEU
TIC.
Srl
A
50,1
7
x
R03A
K11
FLU
TICA
SON
E PR
OPI
ON
ATO
/FO
RMO
TERO
LO F
UM
ARAT
O D
IIDRA
TO
0422
9403
7 FL
UTI
FORM
O
120
dosi
sosp
inal
250
mcg
+ 1
0 m
cg
MU
NDI
PHAR
MA
PHAR
MAC
EUTI
C. S
rl
A 73
,98
x
B03B
B01
ACID
O F
OLI
CO
0406
2702
2 FO
LIFI
LL
120
cpr 5
mg
ITAL
FARM
ACO
SpA
A
13,9
2
R03A
K08
BECL
OM
ETAS
ON
E DI
PRO
PIO
NAT
O/F
ORM
OTE
ROLO
FU
MAR
ATO
03
7778
014
FORM
ODU
AL
solu
z ina
l 120
ero
g 10
0 m
cg +
6 m
cg
PRO
MED
ICA
Srl
A 51
,91
x
R03A
K08
BECL
OM
ETAS
ON
E DI
PRO
PIO
NAT
O/F
ORM
OTE
ROLO
FU
MAR
ATO
03
7778
038
FORM
ODU
AL
polv
inal
120
dos
i 100
mcg
+ 6
mcg
nex
thal
er
PRO
MED
ICA
Srl
A 51
,91
x
R03A
K08
BECL
OM
ETAS
ON
E DI
PRO
PIO
NAT
O/F
ORM
OTE
ROLO
FU
MAR
ATO
03
7778
077
FORM
ODU
AL
solu
z ina
l 120
ero
g 20
0 m
cg +
6 m
cg
PRO
MED
ICA
Srl
A 51
,91
x
R03A
K08
BECL
OM
ETAS
ON
E DI
PRO
PIO
NAT
O/F
ORM
OTE
ROLO
FU
MAR
ATO
03
7778
103
FORM
ODU
AL
polv
inal
120
dos
i 200
mcg
+ 6
mcg
nex
thal
er
PRO
MED
ICA
Srl
A 51
,91
x
H05A
A02
TERI
PARA
TIDE
03
5926
017
FORS
TEO
1
penn
a SC
2,4
ml 2
0 m
cg/8
0 m
cl
ELI L
ILLY
ITAL
IA S
pA
A 52
5,90
A10B
K01
DAPA
GLI
FLO
ZIN
PRO
PAN
EDIO
LO M
ON
OID
RATO
04
2494
070
FORX
IGA
28 c
pr ri
v 10
mg
ASTR
AZEN
ECA
AB
A
56,1
0
x
R03A
K08
BECL
OM
ETAS
ON
E DI
PRO
PIO
NAT
O/F
ORM
OTE
ROLO
FU
MAR
ATO
03
7789
017
FOST
ER
solu
z ina
l 120
ero
g 10
0 m
cg +
6 m
cg
CHIE
SI F
ARM
ACEU
TICI
SpA
A
51,9
1
x
R03A
K08
BECL
OM
ETAS
ON
E DI
PRO
PIO
NAT
O/F
ORM
OTE
ROLO
FU
MAR
ATO
03
7789
031
FOST
ER
polv
inal
120
dos
i 100
mcg
+ 6
mcg
CH
IESI
FAR
MAC
EUTI
CI S
pA
A 51
,91
x
R03A
K08
BECL
OM
ETAS
ON
E DI
PRO
PIO
NAT
O/F
ORM
OTE
ROLO
FU
MAR
ATO
03
7789
070
FOST
ER
solu
z ina
l 120
ero
g 20
0 m
cg +
6 m
cg
CHIE
SI F
ARM
ACEU
TICI
SpA
A
51,9
1
x
R03A
K08
BECL
OM
ETAS
ON
E DI
PRO
PIO
NAT
O/F
ORM
OTE
ROLO
FU
MAR
ATO
03
7789
106
FOST
ER
polv
inal
120
dos
i 200
mcg
+ 6
mcg
CH
IESI
FAR
MAC
EUTI
CI S
pA
A 51
,91
x
S01E
D51
TI
MO
LOLO
MAL
EATO
/BIM
ATO
PRO
ST
0371
4001
1 G
ANFO
RT
colli
rio 3
ml 3
00 m
cg/m
l + 5
mg/
ml
ALLE
RGAN
PH
ARM
ACEU
TIC.
IREL
AND
A
24,7
0
x
S01E
D51
TI
MO
LOLO
MAL
EATO
/BIM
ATO
PRO
ST
0371
4004
7 G
ANFO
RT
colli
rio 3
0 co
nten
itori
mon
odos
e 0,
4 m
l 300
mcg
/ml +
5
mg/
ml
ALLE
RGAN
PH
ARM
ACEU
TIC.
IREL
AND
A
29,7
9
x
A02B
X13
SODI
O A
LGIN
ATO
/PO
TASS
IO B
ICAR
BON
ATO
03
4248
043
GAV
ISCO
N
ADVA
NCE
or
ale
sosp
200
ml
RECK
ITT
BEN
CKIS
ER H
.(IT.
) SpA
A
4,79
A02B
X13
SODI
O A
LGIN
ATO
/PO
TASS
IO B
ICAR
BON
ATO
03
4248
068
GAV
ISCO
N
ADVA
NCE
or
ale
sosp
500
ml
RECK
ITT
BEN
CKIS
ER H
.(IT.
) SpA
A
11,1
1
x
A02B
X13
SODI
O A
LGIN
ATO
/PO
TASS
IO B
ICAR
BON
ATO
03
4248
171
GAV
ISCO
N
ADVA
NCE
20
bus
t ora
le so
sp 1
0 m
l men
ta
RECK
ITT
BEN
CKIS
ER H
.(IT.
) SpA
A
4,79
A02B
X13
SODI
O A
LGIN
ATO
/PO
TASS
IO B
ICAR
BON
ATO
03
4248
284
GAV
ISCO
N
ADVA
NCE
or
ale
sosp
200
ml m
enta
1.0
00 m
g/10
ml +
200
mg/
10 m
l RE
CKIT
T BE
NCK
ISER
H.(I
T.) S
pA
A 4,
79
A02B
X13
SODI
O A
LGIN
ATO
/PO
TASS
IO B
ICAR
BON
ATO
03
4248
346
GAV
ISCO
N
ADVA
NCE
or
ale
sosp
500
ml m
enta
1.0
00 m
g/10
ml +
200
mg/
10 m
l RE
CKIT
T BE
NCK
ISER
H.(I
T.) S
pA
A 11
,11
x
L01X
C15
OBI
NU
TUZU
MAB
04
3533
013
GAZ
YVAR
O
1 fla
conc
ino
solu
z EV
1.0
00 m
g/40
ml
ROCH
E RE
GIS
TRAT
ION
GM
BH
H 2.
828,
63
x
R03A
K07
BUDE
SON
IDE/
FORM
OTE
ROLO
FU
MAR
ATO
DIID
RATO
04
3507
045
GIB
ITER
12
0 do
si 16
0 +
4,5
mcg
pol
v in
al e
asyh
aler
M
ENAR
INI I
NTE
RNAT
. O.L
.S.A
A 49
,31
x
R03A
K07
BUDE
SON
IDE/
FORM
OTE
ROLO
FU
MAR
ATO
DIID
RATO
04
3507
072
GIB
ITER
60
dos
i 320
+ 9
mcg
pol
v in
al e
asyh
aler
M
ENAR
INI I
NTE
RNAT
. O.L
.S.A
A 49
,31
x
— 24 —
GAZZETTA UFFICIALE DELLA REPUBBLICA ITALIANA Serie generale - n. 30227-12-2019
ATC
Prin
cipi
o At
tivo
AIC
Den
omin
azio
ne
Conf
ezio
ne
Tito
lare
AIC
Cl
asse
Pr
ezzo
(€)
PB5
%
2019
R03A
K07
BUDE
SON
IDE/
FORM
OTE
ROLO
FU
MAR
ATO
DIID
RATO
04
3507
134
GIB
ITER
12
0 do
si 80
+ 4
,5 m
cg p
olv
inal
eas
yhal
er
MEN
ARIN
I IN
TERN
AT. O
.L.S
.A
A
37,6
3
x
G03
CA03
ES
TRAD
IOLO
03
4727
014
GIN
AIKO
S ge
l tra
nsd
28 b
ustin
e 1,
5 m
g AB
IOG
EN P
HARM
A Sp
A
A
11,0
9
x
M01
AB16
AC
ECLO
FEN
AC
0312
2001
5 G
LADI
O
40 c
pr ri
v 10
0 m
g AB
IOG
EN P
HARM
A Sp
A
A
10,5
7
M01
AB16
AC
ECLO
FEN
AC
0312
2002
7 G
LADI
O
oral
e po
lv 3
0 bu
st 1
00 m
g AB
IOG
EN P
HARM
A Sp
A
A
8,33
x
H04A
A01
GLU
CAG
ON
E 02
7489
020
GLU
CAG
EN
1 fia
la 1
mg
+ 1
fiala
solv
1 m
l N
OVO
NO
RDIS
K A/
S
H 11
,47
x
H04A
A01
GLU
CAG
ON
E 02
7489
018
GLU
CAG
EN
HYPO
KIT
1 fia
la 1
mg
+ 1
sirin
ga 1
ml
NO
VO N
ORD
ISK
A/S
A
24,0
1
x
L01A
A06
IFO
SFAM
IDE
0237
7906
1 HO
LOXA
N
1 fla
conc
ino
EV 1
g p
olv
BAXT
ER S
pA
H 28
,06
x
C09B
B07
RAM
IPRI
L/AM
LODI
PIN
A BE
SILA
TO
0423
8404
0 IC
OM
B 30
cps
5 m
g +
5 m
g PF
IZER
ITAL
IA S
rl
A 7,
81
C09B
B07
RAM
IPRI
L/AM
LODI
PIN
A BE
SILA
TO
0423
8406
5 IC
OM
B 30
cps
5 m
g +
10 m
g PF
IZER
ITAL
IA S
rl
A 10
,26
C09B
B07
RAM
IPRI
L/AM
LODI
PIN
A BE
SILA
TO
0423
8408
9 IC
OM
B 30
cps
10
mg
+ 5
mg
PFIZ
ER IT
ALIA
Srl
A
9,21
C09B
B07
RAM
IPRI
L/AM
LODI
PIN
A BE
SILA
TO
0423
8410
3 IC
OM
B 30
cps
10
mg
+ 10
mg
PFIZ
ER IT
ALIA
Srl
A
11,6
6
L04A
C08
CAN
AKIN
UM
AB
0394
7201
6 IL
ARIS
1
flaco
ncin
o SC
150
mg
NO
VART
IS E
URO
PHAR
M L
TD
H
10.4
50,0
0
x
L04A
C08
CAN
AKIN
UM
AB
0394
7204
2 IL
ARIS
1
flaco
ncin
o SC
150
mg
1 m
l N
OVA
RTIS
EU
ROPH
ARM
LTD
H
10
.450
,00
x
S01B
A15
FLU
OCI
NO
LON
E AC
ETO
NID
E 04
2616
019
ILU
VIEN
im
pian
to in
trav
itrea
le 1
90 m
cg
ALIM
ERA
SCIE
NCE
S EU
ROPE
LTD
H
7.57
6,25
x
R03B
B07
UM
ECLI
DIN
IO B
ROM
URO
04
3374
026
INCR
USE
ELL
IPTA
30
dos
i pol
v in
alaz
55
mcg
G
LAXO
SMIT
HKLI
NE
(IREL
AND)
LT
D
A 47
,83
x
R03A
K08
BECL
OM
ETAS
ON
E DI
PRO
PIO
NAT
O/F
ORM
OTE
ROLO
FU
MAR
ATO
03
7798
016
INU
VER
solu
z ina
l 120
ero
g 10
0 m
cg +
6 m
cg
CHIE
SI F
ARM
ACEU
TICI
SpA
A
51,9
1
x
R03A
K08
BECL
OM
ETAS
ON
E DI
PRO
PIO
NAT
O/F
ORM
OTE
ROLO
FU
MAR
ATO
03
7798
030
INU
VER
polv
inal
120
dos
i 100
mcg
+ 6
mcg
CH
IESI
FAR
MAC
EUTI
CI S
pA
A 51
,91
x
L01X
E18
RUXO
LITI
NIB
FO
SFAT
O
0422
2605
0 JA
KAVI
56
cpr
5 m
g N
OVA
RTIS
EU
ROPH
ARM
LTD
H
1.
989,
68
x
L01X
E18
RUXO
LITI
NIB
FO
SFAT
O
0422
2608
6 JA
KAVI
56
cpr
15
mg
NO
VART
IS E
URO
PHAR
M L
TD
H
3.97
9,36
x
L01X
E18
RUXO
LITI
NIB
FO
SFAT
O
0422
2611
2 JA
KAVI
56
cpr
20
mg
NO
VART
IS E
URO
PHAR
M L
TD
H
3.97
9,36
x
L01X
E18
RUXO
LITI
NIB
FO
SFAT
O
0422
2615
1 JA
KAVI
56
cpr
10
mg
NO
VART
IS E
URO
PHAR
M L
TD
H
3.97
9,36
x
A10B
D07
SITA
GLI
PTIN
FO
SFAT
O M
ON
OID
RATO
/MET
FORM
INA
CLO
RIDR
ATO
03
8672
034
JAN
UM
ET
56 c
pr ri
v 50
mg
+ 85
0 m
g M
ERCK
SHA
RP &
DO
HME
BV
A 62
,34
x
A10B
D07
SITA
GLI
PTIN
FO
SFAT
O M
ON
OID
RATO
/MET
FORM
INA
CLO
RIDR
ATO
03
8672
109
JAN
UM
ET
56 c
pr ri
v 50
mg
+ 1.
000
mg
MER
CK S
HARP
& D
OHM
E BV
A
62,3
4
x
A10B
H01
SI
TAG
LIPT
IN F
OSF
ATO
MO
NO
IDRA
TO
0377
9302
7 JA
NU
VIA
28 c
pr ri
v 25
mg
MER
CK S
HARP
& D
OHM
E BV
A
62,3
4
x
A10B
H01
SI
TAG
LIPT
IN F
OSF
ATO
MO
NO
IDRA
TO
0377
9308
0 JA
NU
VIA
28 c
pr ri
v 50
mg
MER
CK S
HARP
& D
OHM
E BV
A
62,3
4
x
A10B
H01
SI
TAG
LIPT
IN F
OSF
ATO
MO
NO
IDRA
TO
0377
9314
2 JA
NU
VIA
28 c
pr ri
v 10
0 m
g M
ERCK
SHA
RP &
DO
HME
BV
A 62
,34
x
A10B
K03
EMPA
GLI
FLO
ZIN
04
3443
047
JARD
IAN
CE
28 c
pr ri
v 25
mg
BOEH
RIN
GER
ING
ELHE
IM
INT.
GM
BH
A 62
,34
x
A10B
K03
EMPA
GLI
FLO
ZIN
04
3443
136
JARD
IAN
CE
28 c
pr ri
v 10
mg
BOEH
RIN
GER
ING
ELHE
IM
INT.
GM
BH
A 62
,34
x
— 25 —
GAZZETTA UFFICIALE DELLA REPUBBLICA ITALIANA Serie generale - n. 30227-12-2019
ATC
Prin
cipi
o At
tivo
AIC
Den
omin
azio
ne
Conf
ezio
ne
Tito
lare
AIC
Cl
asse
Pr
ezzo
(€)
PB5
%
2019
A10B
D11
MET
FORM
INA
CLO
RIDR
ATO
/LIN
AGLI
PTIN
04
2203
051
JEN
TADU
ETO
56
cpr
riv
2,5
mg
+ 85
0 m
g BO
EHRI
NG
ER IN
GEL
HEIM
IN
T.G
MBH
A
61,9
0
x
A10B
D11
MET
FORM
INA
CLO
RIDR
ATO
/LIN
AGLI
PTIN
04
2203
190
JEN
TADU
ETO
56
cpr
riv
2,5
mg
+ 1.
000
mg
BOEH
RIN
GER
ING
ELHE
IM
INT.
GM
BH
A 61
,90
x
C03X
A01
TOLV
APTA
N
0442
0201
2 JIN
ARC
7 cp
r 15
mg
OTS
UKA
PH
ARM
ACEU
T.N
ETHE
R.BV
A 55
1,66
x
C03X
A01
TOLV
APTA
N
0442
0203
6 JIN
ARC
7 cp
r 30
mg
OTS
UKA
PH
ARM
ACEU
T.N
ETHE
R.BV
A 55
1,66
x
C03X
A01
TOLV
APTA
N
0442
0207
5 JIN
ARC
28 c
pr 1
5 m
g +
28 c
pr 4
5 m
g O
TSU
KA
PHAR
MAC
EUT.
NET
HER.
BV
A
2.20
6,62
x
C03X
A01
TOLV
APTA
N
0442
0210
1 JIN
ARC
28 c
pr 3
0 m
g +
28 c
pr 6
0 m
g O
TSU
KA
PHAR
MAC
EUT.
NET
HER.
BV
A
2.20
6,62
x
C03X
A01
TOLV
APTA
N
0442
0213
7 JIN
ARC
28 c
pr 3
0 m
g +
28 c
pr 9
0 m
g O
TSU
KA
PHAR
MAC
EUT.
NET
HER.
BV
A
2.20
6,62
x
N04
BD01
SE
LEG
ILIN
A CL
ORI
DRAT
O
0254
6201
9 JU
MEX
50
cpr
5 m
g CH
IESI
FAR
MAC
EUTI
CI S
pA
A 15
,19
N04
BD01
SE
LEG
ILIN
A CL
ORI
DRAT
O
0254
6202
1 JU
MEX
25
cpr
10
mg
CHIE
SI F
ARM
ACEU
TICI
SpA
A
15,9
9
x
C03E
A14
POTA
SSIO
CAN
REN
OAT
O/B
UTI
ZIDE
02
5166
024
KADI
UR
20 c
pr ri
v 50
mg
+ 5
mg
NEO
PHAR
MED
GEN
TILI
SpA
A
6,11
x
M01
AB16
AC
ECLO
FEN
AC
0318
4201
4 KA
FEN
AC
40 c
pr ri
v 10
0 m
g AL
MIR
ALL
S.A.
A 10
,26
M01
AB16
AC
ECLO
FEN
AC
0318
4202
6 KA
FEN
AC
oral
e so
sp p
olv
30 b
ust 1
00 m
g AL
MIR
ALL
S.A.
A 8,
09
x
R07A
X02
IVAC
AFTO
R 04
3519
026
KALY
DECO
56
cpr
riv
150
mg
VERT
EX P
HARM
ACEU
T.IR
ELAN
D LT
D
A 28
.221
,84
x
R07A
X02
IVAC
AFTO
R 04
3519
038
KALY
DECO
or
ale
grat
56
bust
50
mg
VERT
EX
PHAR
MAC
EUT.
IREL
ANDL
TD
A 28
.221
,84
x
R07A
X02
IVAC
AFTO
R 04
3519
040
KALY
DECO
or
ale
grat
56
bust
75
mg
VERT
EX P
HARM
ACEU
T.IR
ELAN
D LT
D
A 28
.221
,84
x
J01M
A17
PRU
LIFL
OXA
CIN
A 03
5680
038
KERA
FLO
X 5
cpr r
iv 6
00 m
g CR
INO
S Sp
A
A 20
,57
x
J02A
B02
KETO
CON
AZO
LO
0437
8101
8 KE
TOCO
NAZ
OLE
HR
A 60
cpr
200
mg
HRA
PHAR
MA
RARE
DIS
ESAS
E
A
816,
18
x
L01X
E42
RI
BOCI
CLIB
SU
CCIN
ATO
04
5618
030
KISQ
ALI
42 c
pr ri
v 20
0 m
g N
OVA
RTIS
EU
ROPH
ARM
LTD
H
3.03
9,27
x
L01X
E42
RI
BOCI
CLIB
SU
CCIN
ATO
04
5618
055
KISQ
ALI
63 c
pr ri
v 20
0 m
g N
OVA
RTIS
EU
ROPH
ARM
LTD
H
4.55
8,90
x
A10B
D10
SAXA
GLI
PTIN
CLO
RIDR
ATO
/MET
FORM
INA
CLO
RIDR
ATO
04
1689
023
KOM
BOG
LYZE
56
cpr
riv
2,5
mg
+ 85
0 m
g AS
TRAZ
ENEC
A AB
A 61
,90
x
A10B
D10
SAXA
GLI
PTIN
CLO
RIDR
ATO
/MET
FORM
INA
CLO
RIDR
ATO
04
1689
086
KOM
BOG
LYZE
56
cpr
riv
2,5
mg
+ 1.
000
mg
ASTR
AZEN
ECA
AB
A
61,9
0
x
L01X
C27
OLA
RATU
MAB
04
5174
012
LART
RUVO
1
flaco
ne E
V 50
ml 1
0 m
g/m
l EL
I LIL
LY IT
ALIA
SpA
A
2.04
8,05
R03A
L03
UM
ECLI
DIN
IO B
ROM
URO
/VIL
ANTE
ROLO
04
3444
025
LAVE
NTA
IR E
LLIP
TA
30 d
osi p
olv
inal
55
mcg
+ 2
2 m
cg
GLA
XOSM
ITHK
LIN
E (IR
ELAN
D)
LTD
A
63,5
0
x
L01A
A02
CLO
RAM
BUCI
LE
0247
9002
6 LE
UKE
RAN
25
cpr
riv
2 m
g AS
PEN
PHA
RMA
TRAD
ING
LI
MIT
ED
A 16
,47
x
R05D
B27
LEVO
DRO
PRO
PIZI
NA
0420
0501
3 LE
VOTU
SS T
OSS
E or
ale
gtt 3
0 m
l 60
mg/
ml
DOM
PE' F
ARM
ACEU
TICI
SpA
A
9,77
x
C08C
A12
BARN
IDIP
INA
CLO
RIDR
ATO
03
5146
012
LIBR
ADIN
28
cps
20
mg
rilas
cio
mod
ifica
to
ALFA
SIG
MA
SpA
A 17
,89
x
C08C
A12
BARN
IDIP
INA
CLO
RIDR
ATO
03
5146
024
LIBR
ADIN
28
cps
10
mg
rilas
cio
mod
ifica
to
ALFA
SIG
MA
SpA
A 17
,89
x
— 26 —
GAZZETTA UFFICIALE DELLA REPUBBLICA ITALIANA Serie generale - n. 30227-12-2019
ATC
Prin
cipi
o At
tivo
AIC
Den
omin
azio
ne
Conf
ezio
ne
Tito
lare
AIC
Cl
asse
Pr
ezzo
(€)
PB5
%
2019
B01A
F03
EDO
XABA
N T
OSI
LATO
04
4315
012
LIXI
ANA*
10CP
R RI
V 15
MG
10
cpr
riv
15 m
g DA
IICHI
SAN
KYO
ITAL
IA S
pA
A 34
,56
B01A
F03
EDO
XABA
N T
OSI
LATO
04
4315
164
LIXI
ANA*
10CP
R RI
V 15
MG
10
x1 c
pr ri
v 15
mg
dose
uni
taria
DA
IICHI
SAN
KYO
ITAL
IA S
pA
A 34
,56
B01A
F03
EDO
XABA
N T
OSI
LATO
04
4315
137
LIXI
ANA*
10CP
R RI
V 30
MG
10
x1 c
pr ri
v 30
mg
DAIIC
HI S
ANKY
O IT
ALIA
SpA
A
34,5
6
B01A
F03
EDO
XABA
N T
OSI
LATO
04
4315
265
LIXI
ANA*
10CP
R RI
V 60
MG
10
x1 c
pr ri
v 60
mg
DAIIC
HI S
ANKY
O IT
ALIA
SpA
A
34,5
6
B01A
F03
EDO
XABA
N T
OSI
LATO
04
4315
051
LIXI
ANA*
28CP
R RI
V 30
MG
28
cpr
riv
30 m
g DA
IICHI
SAN
KYO
ITAL
IA S
pA
A 96
,76
B01A
F03
EDO
XABA
N T
OSI
LATO
04
4315
188
LIXI
ANA*
28CP
R RI
V 60
MG
28
cpr
riv
60 m
g DA
IICHI
SAN
KYO
ITAL
IA S
pA
A 96
,76
B01A
F03
EDO
XABA
N T
OSI
LATO
04
4315
149
LIXI
ANA*
50CP
R RI
V 30
MG
50
x1 c
pr ri
v 30
mg
dose
uni
taria
DA
IICHI
SAN
KYO
ITAL
IA S
pA
A 17
2,79
B01A
F03
EDO
XABA
N T
OSI
LATO
04
4315
277
LIXI
ANA*
50CP
R RI
V 60
MG
50
x1 c
pr ri
v 60
mg
DAIIC
HI S
ANKY
O IT
ALIA
SpA
A
172,
79
H02A
B07
PRED
NIS
ON
E 03
8986
016
LOD
OTR
A 30
cpr
1 m
g ril
asci
o m
odifi
cato
flac
one
MU
NDI
PHAR
MA
PHAR
MAC
EUTI
C. S
rl
A 26
,45
x
H02A
B07
PRED
NIS
ON
E 03
8986
067
LOD
OTR
A 30
cpr
2 m
g ril
asci
o m
odifi
cato
flac
one
MU
NDI
PHAR
MA
PHAR
MAC
EUTI
C. S
rl
A 26
,45
x
H02A
B07
PRED
NIS
ON
E 03
8986
117
LOD
OTR
A 30
cpr
5 m
g ril
asci
o m
odifi
cato
flac
one
MU
NDI
PHAR
MA
PHAR
MAC
EUTI
C. S
rl
A 26
,45
x
S01E
D51
TA
FLU
PRO
ST/T
IMO
LOLO
MAL
EATO
04
3622
012
LOYA
DA
colli
rio 3
0 fla
conc
ini 0
,3 m
l 15
mcg
/ml +
5 m
g/m
l SA
NTE
N IT
ALY
Srl
A
28,8
9
x
S01E
D51
TA
FLU
PRO
ST/T
IMO
LOLO
MAL
EATO
04
3622
024
LOYA
DA
colli
rio 9
0 fla
conc
ini 0
,3 m
l 15
mcg
/ml +
5 m
g/m
l SA
NTE
N IT
ALY
Srl
A
86,6
7
x
S01E
E03
BIM
ATO
PRO
ST
0354
4702
2 LU
MIG
AN
colli
rio 3
ml 0
,1 m
g/m
l AL
LERG
AN
PHAR
MAC
EUTI
C.IR
ELAN
D
A 19
,63
x
S01E
E03
BIM
ATO
PRO
ST
0354
4705
9 LU
MIG
AN
colli
rio 3
0 fla
conc
ini m
onod
ose
0,4
ml 0
,3 m
g/m
l AL
LERG
AN
PHAR
MAC
EUTI
C.IR
ELAN
D
A
22,4
0
G03
GA0
7 LU
TRO
PIN
A AL
FA
0349
5104
4 LU
VERI
S 1
flaco
ncin
o SC
75
UI +
1 fl
acon
cino
solv
M
ERCK
EU
ROPE
BV
A
42,3
3
x
G03
GA0
7 LU
TRO
PIN
A AL
FA
0349
5105
7 LU
VERI
S 3
flaco
ncin
i SC
75 U
I + 3
flac
onci
ni so
lv
MER
CK E
URO
PE B
V
A 12
7,00
x
C03D
A03
CAN
REN
ON
E 02
4273
056
LUVI
ON
20
cps
100
mg
NEO
PHAR
MED
GEN
TILI
SpA
A
7,29
x
C03D
A02
POTA
SSIO
CAN
REN
OAT
O
0242
7307
0 LU
VIO
N
6 fia
le E
V 20
0 m
g +
6 fia
le so
lv 2
ml
NEO
PHAR
MED
GEN
TILI
SpA
H
5,29
x
C03D
A03
CAN
REN
ON
E 02
4273
094
LUVI
ON
40
cpr
50
mg
NEO
PHAR
MED
GEN
TILI
SpA
A
7,42
x
L01X
E25
TRAM
ETIN
IB D
IMET
ILSU
LFO
SSID
O
0435
2402
6 M
EKIN
IST
30 c
pr ri
v 0,
5 m
g fla
cone
N
OVA
RTIS
EU
ROPH
ARM
LTD
H
1.
218,
04
x
L01X
E25
TRAM
ETIN
IB D
IMET
ILSU
LFO
SSID
O
0435
2406
5 M
EKIN
IST
30 c
pr ri
v 2
mg
flaco
ne
NO
VART
IS E
URO
PHAR
M L
TD
H
4.87
2,18
x
A06A
H03
N
ALO
XEG
OL
OSS
ALAT
O
0437
9305
2 M
OVE
NTI
G
30 c
pr ri
v 25
mg
KYO
WA
KIRI
N H
OLD
ING
S B.
V.
A
103,
95
x
L01A
D05
FOTE
MU
STIN
A 02
9376
011
MU
PHO
RAN
1
flaco
ne E
V 20
8 m
g +
1 fia
la so
lv 4
ml
LES
LABO
RATO
IRES
SER
VIER
H
387,
08
x
G03
FB12
ES
TRAD
IOLO
/NO
MEG
ESTR
OLO
ACE
TATO
03
6163
018
NAE
MIS
10
cpr
rosa
1,5
mg
e 14
cpr
bia
nche
1,5
mg
+ 3,
75 m
g TH
ERAM
EX IR
ELAN
D LI
MIT
ED
A 8,
74
M05
BA
SODI
O N
ERID
RON
ATO
03
5268
010
NER
IXIA
1
fiala
IM E
V 25
mg
ABIO
GEN
PHA
RMA
SpA
A 14
,65
x
M05
BA
SODI
O N
ERID
RON
ATO
03
5268
022
NER
IXIA
2
fiale
EV
100
mg
ABIO
GEN
PHA
RMA
SpA
H 60
,58
x
— 27 —
GAZZETTA UFFICIALE DELLA REPUBBLICA ITALIANA Serie generale - n. 30227-12-2019
ATC
Prin
cipi
o At
tivo
AIC
Den
omin
azio
ne
Conf
ezio
ne
Tito
lare
AIC
Cl
asse
Pr
ezzo
(€)
PB5
%
2019
N04
BC09
RO
TIG
OTI
NA
0371
5201
6 N
EUPR
O
7 ce
rott
i tra
nsd
2 m
g/di
e U
CB P
HARM
A S.
A.
A
25,5
1
x
N04
BC09
RO
TIG
OTI
NA
0371
5202
8 N
EUPR
O
28 c
erot
ti tr
ansd
2 m
g/di
e U
CB P
HARM
A S.
A.
A
101,
10
x
N04
BC09
RO
TIG
OTI
NA
0371
5204
2 N
EUPR
O
7 ce
rott
i tra
nsd
4 m
g/di
e U
CB P
HARM
A S.
A.
A
26,4
2
x
N04
BC09
RO
TIG
OTI
NA
0371
5205
5 N
EUPR
O
28 c
erot
ti tr
ansd
4 m
g/di
e U
CB P
HARM
A S.
A.
A
105,
64
x
N04
BC09
RO
TIG
OTI
NA
0371
5207
9 N
EUPR
O
7 ce
rott
i tra
nsd
6 m
g/di
e U
CB P
HARM
A S.
A.
A
34,3
3
x
N04
BC09
RO
TIG
OTI
NA
0371
5208
1 N
EUPR
O
28 c
erot
ti tr
ansd
6 m
g/di
e U
CB P
HARM
A S.
A.
A
137,
33
x
N04
BC09
RO
TIG
OTI
NA
0371
5210
5 N
EUPR
O
7 ce
rott
i tra
nsd
8 m
g/di
e U
CB P
HARM
A S.
A.
A
42,2
6
x
N04
BC09
RO
TIG
OTI
NA
0371
5211
7 N
EUPR
O
28 c
erot
ti tr
ansd
8 m
g/di
e U
CB P
HARM
A S.
A.
A
169,
01
x
S01B
C10
NEP
AFEN
AC
0388
1301
0 N
EVAN
AC
colli
rio 5
ml 1
mg/
ml
NO
VART
IS E
URO
PHAR
M L
TD
H
11,5
4
x
B03A
A01
FERR
OSO
GLI
CIN
A SO
LFAT
O
0367
4301
9 N
IFER
EX
50 c
ps g
astr
ores
100
mg
UCB
PHA
RMA
SpA
A 11
,09
x
A10A
B05
INSU
LIN
A AS
PART
03
4498
232
NO
VORA
PID
PUM
PCAR
T 5
cart
ucce
SC
EV 1
,6 m
l 100
U/m
l N
OVO
NO
RDIS
K A/
S
H 16
,92
x
A10A
B05
INSU
LIN
A AS
PART
03
4498
093
NO
VORA
PID
FLEX
PEN
5
cart
ucce
SC
in p
enne
pre
riem
p 3
ml 1
00 U
/ml
NO
VO N
ORD
ISK
A/S
A
52,3
6
x
A10A
B05
INSU
LIN
A AS
PART
03
4498
030
NO
VORA
PID
PEN
FILL
5
cart
ucce
SC
300
UI 3
ml
NO
VO N
ORD
ISK
A/S
A
52,3
6
x
L01X
E31
NIN
TEDA
NIB
ESI
LATO
04
3827
029
OFE
V 1x
60 c
ps m
olli
100
mg
BOEH
RIN
GER
ING
ELHE
IM
INT.
GM
BH
H 2.
583,
33
x
L01X
E31
NIN
TEDA
NIB
ESI
LATO
04
3827
043
OFE
V 1x
60 c
ps m
olli
150
mg
BOEH
RIN
GER
ING
ELHE
IM
INT.
GM
BH
H 2.
583,
33
x
L04A
A37
BARI
CITI
NIB
04
5260
027
OLU
MIA
NT
28 c
pr ri
v 2
mg
ELI L
ILLY
NED
ERLA
ND
BV
H 66
0,21
x
L04A
A37
BARI
CITI
NIB
04
5260
066
OLU
MIA
NT
84 c
pr ri
v 2
mg
ELI L
ILLY
NED
ERLA
ND
BV
H 1.
980,
64
x
L04A
A37
BARI
CITI
NIB
04
5260
104
OLU
MIA
NT
28 c
pr ri
v 4
mg
ELI L
ILLY
NED
ERLA
ND
BV
H 66
0,21
x
L04A
A37
BARI
CITI
NIB
04
5260
142
OLU
MIA
NT
84 c
pr ri
v 4
mg
ELI L
ILLY
NED
ERLA
ND
BV
H 1.
980,
64
x
D07A
D01
CLO
BETA
SOLO
PRO
PIO
NAT
O
0365
8002
5 O
LUX
schi
uma
cuta
nea
100
g 0,
05%
G
IULI
ANI S
pA
A 13
,01
x
L04A
A24
ABAT
ACEP
T 03
7989
035
ORE
NCI
A 3
flaco
ncin
i EV
250
mg
polv
+ 3
sirin
ghe
BRIS
TOL
M.S
QU
IBB
PHAR
MA
EEIG
H
1.07
7,30
x
L04A
A24
ABAT
ACEP
T 03
7989
086
ORE
NCI
A 4
sirin
ghe
SC 1
25 m
g 1
ml
BRIS
TOL
M.S
QU
IBB
PHAR
MA
EEIG
H
969,
00
x
L04A
A24
ABAT
ACEP
T 03
7989
112
ORE
NCI
A 4
penn
e pr
erie
mp
clic
kjec
t SC
125
mg
1 m
l BR
ISTO
L M
.SQ
UIB
B PH
ARM
A EE
IG
H 96
9,00
x
R07A
X30
LUM
ACAF
TOR/
IVAC
AFTO
R 04
4560
011
ORK
AMBI
11
2 cp
r riv
200
mg
+ 12
5 m
g VE
RTEX
PHA
RMAC
EUT.
IREL
AND
LTD
A
20.3
73,0
4
x
D07A
C13
MO
MET
ASO
NE
FURO
ATO
04
3699
014
OVI
SON
so
luz c
ut 3
0 m
l 1 m
g/g
ABIO
GEN
PHA
RMA
SpA
A 5,
92
x
D07A
C13
MO
MET
ASO
NE
FURO
ATO
04
3699
026
OVI
SON
so
luz c
ut 1
00 m
l 1 m
g/g
ABIO
GEN
PHA
RMA
SpA
A 17
,96
x
D07A
C13
MO
MET
ASO
NE
FURO
ATO
04
3604
026
OVI
XAN
cr
ema
derm
30
g 1
mg/
g AB
IOG
EN P
HARM
A Sp
A
A
5,92
x
— 28 —
GAZZETTA UFFICIALE DELLA REPUBBLICA ITALIANA Serie generale - n. 30227-12-2019
ATC
Prin
cipi
o At
tivo
AIC
Den
omin
azio
ne
Conf
ezio
ne
Tito
lare
AIC
Cl
asse
Pr
ezzo
(€)
PB5
%
2019
D07A
C13
MO
MET
ASO
NE
FURO
ATO
04
3604
038
OVI
XAN
cr
ema
derm
100
g 1
mg/
g AB
IOG
EN P
HARM
A Sp
A
A
17,9
6
x
N02
AA05
O
XICO
DO
NE
CLO
RIDR
ATO
03
4435
014
OXY
CON
TIN
28
cpr
10
mg
rilas
cio
prol
unga
to
MU
NDI
PHAR
MA
PHAR
MAC
EUTI
C. S
rl
A 15
,65
x
N02
AA05
O
XICO
DO
NE
CLO
RIDR
ATO
03
4435
077
OXY
CON
TIN
28
cpr
20
mg
rilas
cio
prol
unga
to
MU
NDI
PHAR
MA
PHAR
MAC
EUTI
C. S
rl
A 30
,86
x
N02
AA05
O
XICO
DO
NE
CLO
RIDR
ATO
03
4435
139
OXY
CON
TIN
28
cpr
40
mg
rilas
cio
prol
unga
to
MU
NDI
PHAR
MA
PHAR
MAC
EUTI
C. S
rl
A 55
,06
x
N02
AA05
O
XICO
DO
NE
CLO
RIDR
ATO
03
4435
192
OXY
CON
TIN
28
cpr
80
mg
rilas
cio
prol
unga
to
MU
NDI
PHAR
MA
PHAR
MAC
EUTI
C. S
rl
A 98
,31
x
N02
AA05
O
XICO
DO
NE
CLO
RIDR
ATO
03
4435
267
OXY
CON
TIN
28
cpr
5 m
g ril
asci
o pr
olun
gato
M
UN
DIPH
ARM
A PH
ARM
ACEU
TIC.
Srl
A
8,61
x
R06A
X28
RUPA
TADI
NA
FUM
ARAT
O
0378
8809
4 PA
FIN
UR
oral
e so
luz
flaco
ne 1
20 m
l 1 m
g/m
l BI
OHO
RM S
.A.
A 8,
87
x
N02
AX06
TA
PEN
TADO
LO C
LORI
DRAT
O
0404
2242
0 PA
LEXI
A 30
cpr
50
mg
rilas
cio
prol
unga
to
GRU
NEN
THAL
ITAL
IA S
rl
A 24
,61
x
N02
AX06
TA
PEN
TADO
LO C
LORI
DRAT
O
0404
2254
5 PA
LEXI
A 30
cpr
100
mg
rilas
cio
prol
unga
to
GRU
NEN
THAL
ITAL
IA S
rl
A 48
,53
x
N02
AX06
TA
PEN
TADO
LO C
LORI
DRAT
O
0404
2266
1 PA
LEXI
A 30
cpr
150
mg
rilas
cio
prol
unga
to
GRU
NEN
THAL
ITAL
IA S
rl
A 62
,62
x
N02
AX06
TA
PEN
TADO
LO C
LORI
DRAT
O
0404
2278
6 PA
LEXI
A 30
cpr
200
mg
rilas
cio
prol
unga
to
GRU
NEN
THAL
ITAL
IA S
rl
A 76
,37
x
N02
AX06
TA
PEN
TADO
LO C
LORI
DRAT
O
0404
2290
1 PA
LEXI
A 30
cpr
250
mg
rilas
cio
prol
unga
to
GRU
NEN
THAL
ITAL
IA S
rl
A 95
,46
x
N02
AX06
TA
PEN
TADO
LO C
LORI
DRAT
O
0404
2384
0 PA
LEXI
A 40
cpr
25
mg
rilas
cio
prol
unga
to
GRU
NEN
THAL
ITAL
IA S
rl
A 16
,40
x
N02
AB03
FE
NTA
NIL
CIT
RATO
04
0328
015
PECF
ENT
1 fla
cone
spr
ay n
asal
e 10
0 m
cg/e
rog
KYO
WA
KIRI
N H
OLD
ING
S B.
V.
A
81,5
2
x
N02
AB03
FE
NTA
NIL
CIT
RATO
04
0328
027
PECF
ENT
4 fla
coni
spra
y na
sale
100
mcg
/ero
gazio
ne
KYO
WA
KIRI
N H
OLD
ING
S B.
V.
A
293,
51
x
N02
AB03
FE
NTA
NIL
CIT
RATO
04
0328
039
PECF
ENT
1 fla
cone
spr
ay n
asal
e 40
0 m
cg/e
rog
KYO
WA
KIRI
N H
OLD
ING
S B.
V.
A
81,5
2
x
N02
AB03
FE
NTA
NIL
CIT
RATO
04
0328
041
PECF
ENT
4 fla
coni
spra
y na
sale
400
mcg
/ero
gazio
ne
KYO
WA
KIRI
N H
OLD
ING
S B.
V.
A
293,
51
x
G03
GA3
0 FO
LLIT
ROPI
NA
ALFA
/LU
TRO
PIN
A AL
FA
0380
8501
5 PE
RGO
VERI
S 1
flaco
ncin
o SC
150
UI +
75
UI +
1 fl
acon
cino
1 m
l M
ERCK
EU
ROPE
BV
A
119,
73
x
G03
GA3
0 FO
LLIT
ROPI
NA
ALFA
/LU
TRO
PIN
A AL
FA
0380
8503
9 PE
RGO
VERI
S 10
flac
onci
ni S
C 15
0 U
I + 7
5 U
I + 1
0 fla
conc
ini 1
ml
MER
CK E
URO
PE B
V
A 1.
197,
24
x
L01X
C13
PERT
UZU
MAB
04
2682
017
PERJ
ETA
1 fia
la E
V 42
0 m
g 14
ml 3
0 m
g/m
l RO
CHE
REG
ISTR
ATIO
N G
MBH
H
2.88
5,93
x
D06B
X02
ING
ENO
LO M
EBU
TATO
04
2513
010
PICA
TO
gel d
erm
0,4
7 g
150
mcg
/g 3
tube
tti
LEO
LAB
ORA
TORI
ES L
TD
A
96,2
7
D06B
X02
ING
ENO
LO M
EBU
TATO
04
2513
022
PICA
TO
gel d
erm
0,4
7 g
500
mcg
/g 2
tube
tti
LEO
LAB
ORA
TORI
ES L
TD
A
96,2
7
A06A
D12
LATT
ITO
LO M
ON
OID
RATO
02
9563
018
PORT
OLA
C EP
S or
ale
polv
200
g
ANG
ELIN
I SpA
A
7,52
x
A06A
D12
LATT
ITO
LO M
ON
OID
RATO
02
9563
044
PORT
OLA
C EP
S sc
iropp
o 50
0 m
l 66,
67 g
/100
ml f
laco
ne
ANG
ELIN
I SpA
A
12,5
5
x
V03A
B37
IDAR
UCI
ZUM
AB
0445
6101
3 PR
AXBI
ND
2 fla
conc
ini E
V 2,
5 g
50 m
l BO
EHRI
NG
ER IN
GEL
HEIM
IN
T.G
MBH
H
2.49
3,75
x
M05
BX04
DE
NO
SUM
AB
0401
0803
3 PR
OLI
A 1
sirin
ga S
C 60
mg
1 m
l AM
GEN
EU
ROPE
B.V
.
A
329,
25
x
G03
DA04
PR
OG
ESTE
RON
E 02
9538
016
PRO
MET
RIU
M
30 c
ps o
rale
vag
100
mg
ROTT
APHA
RM S
pA
A
5,40
x
— 29 —
GAZZETTA UFFICIALE DELLA REPUBBLICA ITALIANA Serie generale - n. 30227-12-2019
ATC
Prin
cipi
o At
tivo
AIC
Den
omin
azio
ne
Conf
ezio
ne
Tito
lare
AIC
Cl
asse
Pr
ezzo
(€)
PB5
%
2019
G03
DA04
PR
OG
ESTE
RON
E 02
9538
028
PRO
MET
RIU
M
15 c
ps o
rale
vag
200
mg
ROTT
APHA
RM S
pA
A
5,40
x
N02
AX02
TR
AMAD
OLO
CLO
RIDR
ATO
03
3074
030
PRO
NTA
LGIN
20
cps
50
mg
NEO
PHAR
MED
GEN
TILI
SpA
A
4,
62
N02
AX02
TR
AMAD
OLO
CLO
RIDR
ATO
03
3074
055
PRO
NTA
LGIN
20
cpr
eff
50 m
g N
EOPH
ARM
ED G
ENTI
LI S
pA
A
4,62
D11A
H01
TA
CRO
LIM
US
MO
NO
IDRA
TO
0355
7501
2 PR
OTO
PIC
ung
derm
30
g 0,
03%
LE
O P
HARM
A A/
S
A
35,0
6
x
D11A
H01
TA
CRO
LIM
US
MO
NO
IDRA
TO
0355
7503
6 PR
OTO
PIC
ung
derm
30
g 0,
1%
LEO
PHA
RMA
A/S
A 39
,43
x
D11A
H01
TA
CRO
LIM
US
MO
NO
IDRA
TO
0355
7505
1 PR
OTO
PIC
ung
derm
10
g 0,
03%
LE
O P
HARM
A A/
S
A
11,6
9
x
D11A
H01
TA
CRO
LIM
US
MO
NO
IDRA
TO
0355
7506
3 PR
OTO
PIC
ung
derm
10
g 0,
1%
LEO
PHA
RMA
A/S
A 13
,14
x
L01B
B02
MER
CAPT
OPU
RIN
A 01
0344
012
PURI
NET
HOL
25 c
pr 5
0 m
g fla
cone
AS
PEN
PHA
RMA
TRAD
ING
LI
MIT
ED
A 31
,94
x
A02B
D08
BISM
UTO
SU
BCIT
RATO
PO
TASS
IO/M
ETRO
NID
AZO
LO/T
ETRA
CICL
INA
CLO
RIDR
ATO
04
1527
019
PYLE
RA
120
cps
140
mg
+ 12
5 m
g +
125
mg
flaco
ne
ALLE
RGAN
PH
ARM
ACEU
T.IN
TERN
.LTD
A
67,4
1
x
S01E
A05
BRIM
ON
IDIN
A TA
RTRA
TO
0438
3201
7 Q
UAL
IDO
FTA
colli
rio 6
0 fla
conc
ini m
onod
ose
0,35
ml 2
mg/
ml
SOO
FT IT
ALIA
SpA
A
12,1
4
x
C01E
B18
RAN
OLA
ZIN
A 03
8917
011
RAN
EXA
60 c
pr 3
75 m
g ril
asci
o pr
olun
gato
M
ENAR
INI I
NTE
RNAT
. O.L
.S.A
A 79
,96
x
C01E
B18
RAN
OLA
ZIN
A 03
8917
035
RAN
EXA
60 c
pr 5
00 m
g ril
asci
o pr
olun
gato
M
ENAR
INI I
NTE
RNAT
. O.L
.S.A
A 79
,96
x
C01E
B18
RAN
OLA
ZIN
A 03
8917
050
RAN
EXA
60 c
pr 7
50 m
g ril
asci
o pr
olun
gato
M
ENAR
INI I
NTE
RNAT
. O.L
.S.A
A 79
,96
x
R03A
K10
FLU
TICA
SON
E FU
ROAT
O/V
ILAN
TERO
LO T
RIFE
NAT
ATO
04
3154
020
RELV
AR E
LLIP
TA
polv
inal
92
mcg
+ 2
2 m
cg 3
0 do
si
GLA
XOSM
ITHK
LIN
E (IR
ELAN
D)
LTD
A
52,1
2
x
R03A
K10
FLU
TICA
SON
E FU
ROAT
O/V
ILAN
TERO
LO T
RIFE
NAT
ATO
04
3154
057
RELV
AR E
LLIP
TA
polv
inal
184
mcg
+ 2
2 m
cg 3
0 do
si
GLA
XOSM
ITHK
LIN
E (IR
ELAN
D)
LTD
A
52,1
2
x
R03A
K10
FLU
TICA
SON
E FU
ROAT
O/V
ILAN
TERO
LO T
RIFE
NAT
ATO
04
3446
020
REVI
NTY
ELL
IPTA
po
lv in
al 9
2 m
cg +
22
mcg
30
dosi
G
LAXO
SMIT
HKLI
NE
(IREL
AND)
LT
D
A 52
,12
x
R03A
K10
FLU
TICA
SON
E FU
ROAT
O/V
ILAN
TERO
LO T
RIFE
NAT
ATO
04
3446
057
REVI
NTY
ELL
IPTA
po
lv in
al 1
84 m
cg +
22
mcg
30
dosi
G
LAXO
SMIT
HKLI
NE
(IREL
AND)
LT
D
A 52
,12
x
B02B
X05
ELTR
OM
BOPA
G O
LAM
INA
0398
2702
3 RE
VOLA
DE
28 c
pr ri
v 25
mg
NO
VART
IS E
URO
PHAR
M L
TD
H 1.
142,
38
x
B02B
X05
ELTR
OM
BOPA
G O
LAM
INA
0398
2705
0 RE
VOLA
DE
28 c
pr ri
v 50
mg
NO
VART
IS E
URO
PHAR
M L
TD
H 2.
284,
75
x
R03B
B07
UM
ECLI
DIN
IO B
ROM
URO
04
5321
027
ROLU
FTA
ELLI
PTA
1 in
al 3
0 do
si 55
mcg
G
LAXO
SMIT
HKLI
NE
TRAD
.SER
V.LT
D
A 47
,83
x
S01E
E05
TAFL
UPR
OST
03
8926
034
SAFL
UTA
N
colli
rio 3
0 fla
conc
ini 1
5 m
cg/m
l 0,3
ml
SAN
TEN
ITAL
Y Sr
l
A 25
,94
x
C03X
A01
TOLV
APTA
N
0395
5101
5 SA
MSC
A 10
x1 c
pr 1
5 m
g O
TSU
KA
PHAR
MAC
EUT.
NET
HER.
BV
H
741,
00
x
C03X
A01
TOLV
APTA
N
0395
5103
9 SA
MSC
A 10
x1 c
pr 3
0 m
g O
TSU
KA
PHAR
MAC
EUT.
NET
HER.
BV
H
741,
00
x
A04A
A02
GRA
NIS
ETRO
NE
0429
2401
1 SA
NCU
SO
1 ce
rott
o tr
ansd
erm
ico
3,1
mg/
24 o
re
KYO
WA
KIRI
N H
OLD
ING
S B.
V.
A
90,9
3
x
M01
AE14
DE
XIBU
PRO
FEN
E 03
4765
154
SERA
CTIL
30
cpr
riv
400
mg
NEO
PHAR
MED
GEN
TILI
SpA
A
7,42
x
M01
AE14
DE
XIBU
PRO
FEN
E 03
4765
228
SERA
CTIL
or
ale
polv
30
bust
400
mg
NEO
PHAR
MED
GEN
TILI
SpA
A
7,42
x
H01C
B05
PASI
REO
TIDE
DIA
SPAR
TATO
04
2032
045
SIG
NIF
OR
SC 6
0 fia
le 0
,3 m
g 1
ml
NO
VART
IS E
URO
PHAR
M L
TD
A
5.38
9,21
x
— 30 —
GAZZETTA UFFICIALE DELLA REPUBBLICA ITALIANA Serie generale - n. 30227-12-2019
ATC
Prin
cipi
o At
tivo
AIC
Den
omin
azio
ne
Conf
ezio
ne
Tito
lare
AIC
Cl
asse
Pr
ezzo
(€)
PB5
%
2019
H01C
B05
PASI
REO
TIDE
DIA
SPAR
TATO
04
2032
084
SIG
NIF
OR
SC 6
0 fia
le 0
,6 m
g 1
ml
NO
VART
IS E
URO
PHAR
M L
TD
A
6.34
0,25
x
H01C
B05
PASI
REO
TIDE
DIA
SPAR
TATO
04
2032
122
SIG
NIF
OR
SC 6
0 fia
le 0
,9 m
g 1
ml
NO
VART
IS E
URO
PHAR
M L
TD
A
6.34
0,25
x
H01C
B05
PASI
REO
TIDE
PAM
OAT
O
0420
3213
4 SI
GN
IFO
R IM
1 fl
acon
cino
pol
v 20
mg
+ sir
inga
2 m
l N
OVA
RTIS
EU
ROPH
ARM
LTD
A
5.02
9,94
x
H01C
B05
PASI
REO
TIDE
PAM
OAT
O
0420
3214
6 SI
GN
IFO
R IM
1 fl
acon
cino
pol
v 40
mg
+ sir
inga
2 m
l N
OVA
RTIS
EU
ROPH
ARM
LTD
A
5.91
7,57
x
H01C
B05
PASI
REO
TIDE
PAM
OAT
O
0420
3216
1 SI
GN
IFO
R IM
1 fl
acon
cino
pol
v 60
mg
+ sir
inga
2 m
l N
OVA
RTIS
EU
ROPH
ARM
LTD
A
6.80
5,21
x
G04
CA04
SI
LODO
SIN
A 03
9775
046
SILO
DYX
30 c
ps 4
mg
RECO
RDAT
I IRE
LAN
D LT
D
A 7,
70
x
G04
CA04
SI
LODO
SIN
A 03
9775
111
SILO
DYX
30 c
ps 8
mg
RECO
RDAT
I IRE
LAN
D LT
D
A 15
,40
x
R03A
K07
BUDE
SON
IDE/
FORM
OTE
ROLO
FU
MAR
ATO
DIID
RATO
03
5260
064
SIN
ESTI
C TU
RBO
HALE
R po
lv in
al 1
20 d
osi 1
60 m
cg +
4,5
mcg
AS
TRAZ
ENEC
A Sp
A
A 62
,41
x
R03A
K07
BUDE
SON
IDE/
FORM
OTE
ROLO
FU
MAR
ATO
DIID
RATO
03
5260
215
SIN
ESTI
C TU
RBO
HALE
R po
lv in
al 6
0 do
si 32
0 m
cg +
9 m
cg
ASTR
AZEN
ECA
SpA
A
62,4
1
x
N04
BA05
M
ELEV
OD
OPA
CLO
RIDR
ATO
/CAR
BIDO
PA ID
RATA
03
5625
060
SIRI
O
60 c
pr e
ff 12
,5 m
g +
125
mg
CHIE
SI F
ARM
ACEU
TICI
SpA
A
19,7
1
x
N04
BA05
M
ELEV
OD
OPA
CLO
RIDR
ATO
/CAR
BIDO
PA ID
RATA
03
5625
072
SIRI
O
60 c
pr e
ff 25
mg
+ 10
0 m
g CH
IESI
FAR
MAC
EUTI
CI S
pA
A 19
,71
x
D11A
X18
DICL
OFE
NAC
SO
DICO
03
4129
039
SOLA
RAZE
ge
l der
m 6
0 g
3%
ALM
IRAL
L Sp
A A
51,6
4
D11A
X18
DICL
OFE
NAC
SO
DICO
03
4129
041
SOLA
RAZE
ge
l der
m 9
0 g
3%
ALM
IRAL
L Sp
A A
77,4
5
R03A
L06
TIO
TRO
PIO
BRO
MU
RO/O
LODA
TERO
LO C
LORI
DRAT
O
0436
6101
4 SP
IOLT
O R
ESPI
MAT
so
luz i
nal 1
inal
ator
e 2,
5 m
cg +
2,5
mcg
da
60 e
roga
zioni
BO
EHRI
NG
ER IN
GEL
HEIM
IN
T.G
MBH
A
63,5
0
x
R03B
B04
TIO
TRO
PIO
BRO
MU
RO
0388
8001
1 SP
IRIV
A RE
SPIM
AT
solu
z ina
l 60
erog
azio
ni 2
,5 m
cg
BOEH
RIN
GER
ING
ELHE
IM
INT.
GM
BH
A 48
,78
x
L01X
E21
REG
ORA
FEN
IB
0429
2502
6 ST
IVAR
GA
3x28
cpr
riv
40 m
g fla
cone
BA
YER
AG
A
3.44
9,34
x
A10A
E54
INSU
LIN
A G
LARG
INE/
LIXI
SEN
ATID
E 04
5254
012
SULI
QU
A 3
penn
e pr
erie
mpi
te 3
ml 1
00 U
/ml +
50
mcg
/ml
SAN
OFI
-AVE
NTI
S G
ROU
PE
A
166,
77
x
A10A
E54
INSU
LIN
A G
LARG
INE/
LIXI
SEN
ATID
E 04
5254
036
SULI
QU
A 3
penn
e pr
erie
mpi
te 3
ml 1
00 U
/ml +
33
mcg
/ml
SAN
OFI
-AVE
NTI
S G
ROU
PE
A
166,
77
x
N01
AB07
DE
SFLU
RAN
O
0292
8804
0 SU
PRAN
E 6
flaco
ni li
q in
al 2
40 m
l in
allu
min
io
BAXT
ER S
pA
H 56
7,73
x
R03A
K07
BUDE
SON
IDE/
FORM
OTE
ROLO
FU
MAR
ATO
DIID
RATO
03
5194
063
SYM
BICO
RT
TURB
OHA
LER
polv
inal
120
dos
i 160
mcg
+ 4
,5 m
cg
ASTR
AZEN
ECA
SpA
A
61,1
6
x
R03A
K07
BUDE
SON
IDE/
FORM
OTE
ROLO
FU
MAR
ATO
DIID
RATO
03
5194
214
SYM
BICO
RT
TURB
OHA
LER
polv
inal
60
dosi
320
mcg
+ 9
mcg
AS
TRAZ
ENEC
A Sp
A
A 62
,41
x
R03A
K07
BUDE
SON
IDE/
FORM
OTE
ROLO
FU
MAR
ATO
DIID
RATO
03
5194
265
SYM
BICO
RT
sosp
pre
ss in
al 1
20 d
osi 1
60 m
cg +
4,5
mcg
AS
TRAZ
ENEC
A Sp
A
A 62
,42
x
R03A
K07
BUDE
SON
IDE/
FORM
OTE
ROLO
FU
MAR
ATO
DIID
RATO
03
5603
063
SYM
BICO
RT M
ITE
polv
inal
120
dos
i 80
mcg
+ 4
,5 m
cg tu
rboh
aler
AS
TRAZ
ENEC
A Sp
A
A 49
,42
x
A10B
D20
EMPA
GLI
FLO
ZIN
/MET
FORM
INA
CLO
RIDR
ATO
04
4229
045
SYN
JARD
Y 56
x1 c
pr ri
v 5
mg
+ 85
0 m
g BO
EHRI
NG
ER IN
GEL
HEIM
IN
T.G
MBH
A
62,3
4
x
A10B
D20
EMPA
GLI
FLO
ZIN
/MET
FORM
INA
CLO
RIDR
ATO
04
4229
134
SYN
JARD
Y 56
x1 c
pr ri
v 5
mg
+ 1.
000
mg
BOEH
RIN
GER
ING
ELHE
IM
INT.
GM
BH
A 62
,34
x
A10B
D20
EMPA
GLI
FLO
ZIN
/MET
FORM
INA
CLO
RIDR
ATO
04
4229
223
SYN
JARD
Y 56
x1 c
pr ri
v 12
,5 m
g +
850
mg
BOEH
RIN
GER
ING
ELHE
IM
INT.
GM
BH
A 62
,34
x
A10B
D20
EMPA
GLI
FLO
ZIN
/MET
FORM
INA
CLO
RIDR
ATO
04
4229
312
SYN
JARD
Y 56
cpr
riv
12,5
mg
+ 1.
000
mg
BOEH
RIN
GER
ING
ELHE
IM
INT.
GM
BH
A 62
,34
x
— 31 —
GAZZETTA UFFICIALE DELLA REPUBBLICA ITALIANA Serie generale - n. 30227-12-2019
ATC
Prin
cipi
o At
tivo
AIC
Den
omin
azio
ne
Conf
ezio
ne
Tito
lare
AIC
Cl
asse
Pr
ezzo
(€)
PB5
%
2019
S01B
A05
TRIA
MCI
NO
LON
E AC
ETO
NID
E 04
0637
011
TAIO
FTAL
1
flaco
ncin
o 80
mg
1 m
l uso
intr
avitr
eo
SOO
FT IT
ALIA
SpA
H
76,3
8
x
L04A
C13
IXEK
IZU
MAB
04
4863
025
TALT
Z SC
2 p
enne
pre
riem
p 1
ml 8
0 m
g EL
I LIL
LY N
EDER
LAN
D BV
H
2.02
5,40
x
L04A
C13
IXEK
IZU
MAB
04
4863
037
TALT
Z SC
3 p
enne
pre
riem
p 1
ml 8
0 m
g EL
I LIL
LY N
EDER
LAN
D BV
H
3.03
8,10
x
L04A
C13
IXEK
IZU
MAB
04
4863
052
TALT
Z SC
2 si
ringh
e pr
erie
mp
1 m
l 80
mg
ELI L
ILLY
NED
ERLA
ND
BV
H 2.
025,
40
x
L04A
C13
IXEK
IZU
MAB
04
4863
064
TALT
Z SC
3 si
ringh
e pr
erie
mp
1 m
l 80
mg
ELI L
ILLY
NED
ERLA
ND
BV
H 3.
038,
10
x
N02
AA55
O
XICO
DO
NE
CLO
RIDR
ATO
/NAL
OXO
NE
CLO
RIDR
ATO
DIID
RATO
03
9586
045
TARG
IN
28 c
pr ri
v 5
mg
+ 2,
5 m
g ril
asci
o pr
olun
gato
M
UN
DIPH
ARM
A PH
ARM
ACEU
TIC.
Srl
A
18,4
4
x
N02
AA55
O
XICO
DO
NE
CLO
RIDR
ATO
/NAL
OXO
NE
CLO
RIDR
ATO
DIID
RATO
03
9586
159
TARG
IN
28 c
pr ri
v 10
mg
+ 5
mg
rilas
cio
prol
unga
to
MU
NDI
PHAR
MA
PHAR
MAC
EUTI
C. S
rl
A 26
,49
x
N02
AA55
O
XICO
DO
NE
CLO
RIDR
ATO
/NAL
OXO
NE
CLO
RIDR
ATO
DIID
RATO
03
9586
262
TARG
IN
28 c
pr ri
v 20
mg
+ 10
mg
rilas
cio
prol
unga
to
MU
NDI
PHAR
MA
PHAR
MAC
EUTI
C. S
rl
A 46
,09
x
N02
AA55
O
XICO
DO
NE
CLO
RIDR
ATO
/NAL
OXO
NE
CLO
RIDR
ATO
DIID
RATO
03
9586
375
TARG
IN
28 c
pr 4
0 m
g +
20 m
g ril
asci
o pr
olun
gato
M
UN
DIPH
ARM
A PH
ARM
ACEU
TIC.
Srl
A
80,9
0
x
R05D
B27
LEVO
DRO
PRO
PIZI
NA
0269
7301
4 TA
UTU
X sc
iropp
o 1
flaco
ne 2
00 m
l 30
mg/
5 m
l AL
FASI
GM
A Sp
A
A
6,53
x
R05D
B27
LEVO
DRO
PRO
PIZI
NA
0269
7302
6 TA
UTU
X or
ale
gtt 3
0 m
l 6%
AL
FASI
GM
A Sp
A
A
9,77
x
N07
XX02
RI
LUZO
LO
0420
1801
0 TE
GLU
TIK
oral
e so
sp fl
acon
e 30
0 m
l 5 m
g/m
l IT
ALFA
RMAC
O S
pA
A
12
6,83
x
A10B
H01
SI
TAG
LIPT
IN F
OSF
ATO
MO
NO
IDRA
TO
0384
4802
7 TE
SAVE
L 28
cpr
riv
25 m
g M
ERCK
SHA
RP &
DO
HME
BV
A 62
,34
x
A10B
H01
SI
TAG
LIPT
IN F
OSF
ATO
MO
NO
IDRA
TO
0384
4808
0 TE
SAVE
L 28
cpr
riv
50 m
g M
ERCK
SHA
RP &
DO
HME
BV
A 62
,34
x
A10B
H01
SI
TAG
LIPT
IN F
OSF
ATO
MO
NO
IDRA
TO
0384
4814
2 TE
SAVE
L 28
cpr
riv
100
mg
MER
CK S
HARP
& D
OHM
E BV
A
62,3
4
x
C09C
A02
EPRO
SART
AN M
ESIL
ATO
03
3331
149
TEVE
TEN
Z 28
cpr
riv
600
mg
MYL
AN IR
E HE
ALTH
CARE
LI
MIT
ED
A 19
,47
x
C09D
A02
EPRO
SART
AN M
ESIL
ATO
/IDR
OCL
ORO
TIAZ
IDE
0367
7201
0 TI
ARTA
N
28 c
pr ri
v 60
0 m
g +
12,5
mg
MYL
AN IR
E HE
ALTH
CARE
LI
MIT
ED
A 23
,94
x
L01B
B03
TIO
GU
ANIN
A 02
2825
018
TIO
GU
ANIN
A AS
PEN
25
cpr
40
mg
ASPE
N P
HARM
A TR
ADIN
G
LIM
ITED
A
148,
57
x
A07A
A11
RIFA
XIM
INA
0419
2404
6 TI
XTEL
LER
56 c
pr ri
v 55
0 m
g AL
FASI
GM
A Sp
A
A
254,
56
x
G03
BA03
TE
STO
STER
ON
E 03
7314
010
TOST
REX
gel m
ultid
ose
60 g
2%
con
dos
ator
e KY
OW
A KI
RIN
HO
LDIN
GS
B.V.
A 53
,47
x
A10B
H05
LI
NAG
LIPT
IN
0414
0103
5 TR
AJEN
TA
28 c
pr ri
v 5
mg
BOEH
RIN
GER
ING
ELHE
IM
INT.
GM
BH
A 61
,90
x
N02
AX02
TR
AMAD
OLO
CLO
RIDR
ATO
03
5986
025
TRAL
ODI
E 20
cps
100
mg
rilas
cio
prol
unga
to
NEO
PHAR
MED
GEN
TILI
SpA
A
8,94
x
N02
AX02
TR
AMAD
OLO
CLO
RIDR
ATO
03
5986
052
TRAL
ODI
E 10
cps
150
mg
rilas
cio
prol
unga
to
NEO
PHAR
MED
GEN
TILI
SpA
A
6,71
x
N02
AX02
TR
AMAD
OLO
CLO
RIDR
ATO
03
5986
090
TRAL
ODI
E 10
cps
200
mg
rilas
cio
prol
unga
to
NEO
PHAR
MED
GEN
TILI
SpA
A
8,94
x
M09
AX03
AT
ALU
REN
04
3535
018
TRAN
SLAR
NA
oral
e gr
at 3
0 bu
st 1
25 m
g PT
C TH
ERAP
EUTI
CS
INTE
RNAT
.LTD
H
2.88
9,90
x
M09
AX03
AT
ALU
REN
04
3535
020
TRAN
SLAR
NA
oral
e gr
at 3
0 bu
st 2
50 m
g PT
C TH
ERAP
EUTI
CS
INTE
RNAT
.LTD
H
5.77
9,80
x
M09
AX03
AT
ALU
REN
04
3535
032
TRAN
SLAR
NA
oral
e gr
at 3
0 bu
st 1
.000
mg
PTC
THER
APEU
TICS
IN
TERN
AT.L
TD
H 23
.119
,20
x
— 32 —
GAZZETTA UFFICIALE DELLA REPUBBLICA ITALIANA Serie generale - n. 30227-12-2019
ATC
Prin
cipi
o At
tivo
AIC
Den
omin
azio
ne
Conf
ezio
ne
Tito
lare
AIC
Cl
asse
Pr
ezzo
(€)
PB5
%
2019
A10A
E06
INSU
LIN
A D
EGLU
DEC
0426
5802
9 TR
ESIB
A FL
EXTO
UCH
SC
5 pe
nne
prer
iem
p 3
ml 1
00 U
/ml
NO
VO N
ORD
ISK
A/S
A
144,
29
x
R03A
L09
BECL
OM
ETAS
ON
E DI
PRO
PIO
NAT
O/F
ORM
OTE
ROLO
FU
MAR
ATO
DI
IDRA
TO/G
LICO
PIRR
ON
IO B
ROM
URO
04
5489
022
TRIM
BOW
so
luz i
nal 1
20 e
rog
87 m
cg +
5 m
cg +
9 m
cg
CHIE
SI F
ARM
ACEU
TICI
SpA
A
91,6
7
x
C09B
X01
PERI
NDO
PRIL
ARG
ININ
A/IN
DAPA
MID
E/AM
LODI
PIN
A BE
SILA
TO
0424
0706
6 TR
IPLI
AM
30 c
pr ri
v 5
mg
+ 1,
25 m
g +
5 m
g fla
cone
LE
S LA
BORA
TOIR
ES S
ERVI
ER
A 14
,16
x
C09B
X01
PERI
NDO
PRIL
ARG
ININ
A/IN
DAPA
MID
E/AM
LODI
PIN
A BE
SILA
TO
0424
0711
6 TR
IPLI
AM
30 c
pr ri
v 5
mg
+ 1,
25 m
g +
10 m
g fla
cone
LE
S LA
BORA
TOIR
ES S
ERVI
ER
A 14
,16
x
C09B
X01
PERI
NDO
PRIL
ARG
ININ
A/IN
DAPA
MID
E/AM
LODI
PIN
A BE
SILA
TO
0424
0716
7 TR
IPLI
AM
30 c
pr ri
v 10
mg
+ 2,
5 m
g +
5 m
g fla
cone
LE
S LA
BORA
TOIR
ES S
ERVI
ER
A 13
,56
x
C09B
X01
PERI
NDO
PRIL
ARG
ININ
A/IN
DAPA
MID
E/AM
LODI
PIN
A BE
SILA
TO
0424
0721
7 TR
IPLI
AM
30 c
pr ri
v 10
mg
+ 2,
5 m
g +
10 m
g fla
cone
LE
S LA
BORA
TOIR
ES S
ERVI
ER
A 15
,00
x
N06
AX05
TR
AZO
DON
E CL
ORI
DRAT
O
0223
2301
2 TR
ITTI
CO
3 fia
le IM
EV
50 m
g 5
ml
ANG
ELIN
I SpA
A
2,
38
N06
AX05
TR
AZO
DON
E CL
ORI
DRAT
O
0223
2303
6 TR
ITTI
CO
30 c
pr d
iv 5
0 m
g AN
GEL
INI S
pA
A
4,86
N06
AX05
TR
AZO
DON
E CL
ORI
DRAT
O
0223
2304
8 TR
ITTI
CO
30 c
pr d
iv 1
00 m
g AN
GEL
INI S
pA
A 8,
84
x
N06
AX05
TR
AZO
DON
E CL
ORI
DRAT
O
0223
2306
3 TR
ITTI
CO
30 c
pr d
iv 7
5 m
g ril
asci
o pr
olun
gato
AN
GEL
INI S
pA
A 6,
80
x
N06
AX05
TR
AZO
DON
E CL
ORI
DRAT
O
0223
2307
5 TR
ITTI
CO
20 c
pr d
iv 1
50 m
g ril
asci
o pr
olun
gato
AN
GEL
INI S
pA
A 9,
02
x
N06
AX05
TR
AZO
DON
E CL
ORI
DRAT
O
0223
2309
9 TR
ITTI
CO
oral
e gt
t 30
ml 6
0 m
g/m
l AN
GEL
INI S
pA
A 7,
11
x
N06
AX05
TR
AZO
DON
E CL
ORI
DRAT
O
0223
2311
3 TR
ITTI
CO
14 c
pr ri
v CO
NTR
AMID
150
mg
rilas
cio
prol
unga
to
ANG
ELIN
I SpA
A
6,23
x
N06
AX05
TR
AZO
DON
E CL
ORI
DRAT
O
0223
2319
0 TR
ITTI
CO
30 c
pr ri
v CO
NTR
AMID
300
mg
rilas
cio
prol
unga
to
ANG
ELIN
I SpA
A
23,8
7
x
A10B
J05
DULA
GLU
TIDE
04
3783
024
TRU
LICI
TY
4 pe
nne
prer
iem
pite
SC
0,5
ml 0
,75
mg
ELI L
ILLY
NED
ERLA
ND
BV
A 16
1,56
x
A10B
J05
DULA
GLU
TIDE
04
3783
075
TRU
LICI
TY
4 pe
nne
prer
iem
pite
SC
1,5
mg
0,5
ml
ELI L
ILLY
NED
ERLA
ND
BV
A 16
1,56
x
N02
AA01
M
ORF
INA
SOLF
ATO
03
3484
015
TWIC
E 16
cps
10
mg
rilas
cio
prol
unga
to
ETH
YPHA
RM S
.A.
A
4,
96
N02
AA01
M
ORF
INA
SOLF
ATO
03
3484
027
TWIC
E 16
cps
30
mg
rilas
cio
prol
unga
to
ETH
YPHA
RM S
.A.
A
8,96
x
N02
AA01
M
ORF
INA
SOLF
ATO
03
3484
039
TWIC
E 16
cps
60
mg
rilas
cio
prol
unga
to
ETH
YPHA
RM S
.A.
A
16,5
7
x
N02
AA01
M
ORF
INA
SOLF
ATO
03
3484
041
TWIC
E 16
cps
100
mg
rilas
cio
prol
unga
to
ETH
YPHA
RM S
.A.
A
24,1
5
x
R03A
L04
INDA
CATE
ROLO
MAL
EATO
/GLI
COPI
RRO
NIO
BRO
MU
RO
0430
3103
2 U
LTIB
RO
BREE
ZHAL
ER
polv
inal
30x
1 cp
s 85
mcg
+ 4
3 m
cg
NO
VART
IS E
URO
PHAR
M L
TD
A
63,5
0
x
J01M
A17
PRU
LIFL
OXA
CIN
A 03
5678
022
UN
IDRO
X 5
cpr r
iv 6
00 m
g AN
GEL
INI S
pA
A 20
,57
x
J01M
A17
PRU
LIFL
OXA
CIN
A 03
5678
034
UN
IDRO
X 1
cpr r
iv 6
00 m
g AN
GEL
INI S
pA
A 8,
66
x
G04
CA04
SI
LODO
SIN
A 03
9789
045
URO
REC
30 c
ps 4
mg
RECO
RDAT
I IRE
LAN
D LT
D
A 7,
70
x
G04
CA04
SI
LODO
SIN
A 03
9789
110
URO
REC
30 c
ps 8
mg
RECO
RDAT
I IRE
LAN
D LT
D
A 15
,40
x
L01X
E31
NIN
TEDA
NIB
ESI
LATO
04
3782
022
VARG
ATEF
12
0 cp
s m
olli
100
mg
BOEH
RIN
GER
ING
ELHE
IM
INT.
GM
BH
H 2.
583,
33
x
L01X
E31
NIN
TEDA
NIB
ESI
LATO
04
3782
046
VARG
ATEF
60
cps
mol
li 15
0 m
g BO
EHRI
NG
ER IN
GEL
HEIM
IN
T.G
MBH
H
2.58
3,33
x
C08C
A12
BARN
IDIP
INA
CLO
RIDR
ATO
03
5144
017
VASE
XTEN
28
cps
20
mg
rilas
cio
mod
ifica
to
ITAL
FARM
ACO
SpA
A
17,8
9
x
— 33 —
GAZZETTA UFFICIALE DELLA REPUBBLICA ITALIANA Serie generale - n. 30227-12-2019
ATC
Prin
cipi
o At
tivo
AIC
Den
omin
azio
ne
Conf
ezio
ne
Tito
lare
AIC
Cl
asse
Pr
ezzo
(€)
PB5
%
2019
C08C
A12
BARN
IDIP
INA
CLO
RIDR
ATO
03
5144
029
VASE
XTEN
28
cps
10
mg
rilas
cio
mod
ifica
to
ITAL
FARM
ACO
SpA
A
17,8
9
x
N02
AB03
FE
NTA
NIL
CIT
RATO
04
2415
063
VELL
OFE
NT
4 cp
r sub
ling
67 m
cg
ANG
ELIN
I SpA
A
40,7
6
x
N02
AB03
FE
NTA
NIL
CIT
RATO
04
2415
087
VELL
OFE
NT
30 c
pr s
ublin
g 67
mcg
AN
GEL
INI S
pA
A 23
8,20
x
N02
AB03
FE
NTA
NIL
CIT
RATO
04
2415
149
VELL
OFE
NT
4 cp
r sub
ling
133
mcg
AN
GEL
INI S
pA
A 40
,76
x
N02
AB03
FE
NTA
NIL
CIT
RATO
04
2415
164
VELL
OFE
NT
30 c
pr s
ublin
g 13
3 m
cg
ANG
ELIN
I SpA
A
238,
20
x
N02
AB03
FE
NTA
NIL
CIT
RATO
04
2415
226
VELL
OFE
NT
4 cp
r sub
ling
267
mcg
AN
GEL
INI S
pA
A 40
,76
x
N02
AB03
FE
NTA
NIL
CIT
RATO
04
2415
240
VELL
OFE
NT
30 c
pr s
ublin
g 26
7 m
cg
ANG
ELIN
I SpA
A
238,
20
x
N02
AB03
FE
NTA
NIL
CIT
RATO
04
2415
303
VELL
OFE
NT
4 cp
r sub
ling
400
mcg
AN
GEL
INI S
pA
A 40
,76
x
N02
AB03
FE
NTA
NIL
CIT
RATO
04
2415
327
VELL
OFE
NT
30 c
pr s
ublin
g 40
0 m
cg
ANG
ELIN
I SpA
A
238,
20
x
N02
AB03
FE
NTA
NIL
CIT
RATO
04
2415
380
VELL
OFE
NT
4 cp
r sub
ling
533
mcg
AN
GEL
INI S
pA
A 40
,76
x
N02
AB03
FE
NTA
NIL
CIT
RATO
04
2415
404
VELL
OFE
NT
30 c
pr s
ublin
g 53
3 m
cg
ANG
ELIN
I SpA
A
238,
20
x
N02
AB03
FE
NTA
NIL
CIT
RATO
04
2415
467
VELL
OFE
NT
4 cp
r sub
ling
800
mcg
AN
GEL
INI S
pA
A 40
,76
x
N02
AB03
FE
NTA
NIL
CIT
RATO
04
2415
481
VELL
OFE
NT
30 c
pr s
ublin
g 80
0 m
cg
ANG
ELIN
I SpA
A
238,
20
x
D05A
X04
TACA
LCIT
OLO
MO
NO
IDRA
TO
0314
9401
4 VE
LLU
TAN
un
g de
rm 2
0 g
4 m
cg/g
AB
IOG
EN P
HARM
A Sp
A
A
13,1
0
x
D05A
X04
TACA
LCIT
OLO
MO
NO
IDRA
TO
0314
9402
6 VE
LLU
TAN
em
uls c
ut 2
0 m
l 4 m
cg/g
AB
IOG
EN P
HARM
A Sp
A
A
12,5
3
x
D05A
X04
TACA
LCIT
OLO
MO
NO
IDRA
TO
0314
9404
0 VE
LLU
TAN
em
uls c
ut 5
0 m
l 4 m
cg/g
AB
IOG
EN P
HARM
A Sp
A
A
20,6
5
x
A10B
D07
SITA
GLI
PTIN
FO
SFAT
O M
ON
OID
RATO
/MET
FORM
INA
CLO
RIDR
ATO
03
8678
037
VELM
ETIA
56
cpr
riv
50 m
g +
850
mg
MER
CK S
HARP
& D
OHM
E BV
A
62,3
4
x
A10B
D07
SITA
GLI
PTIN
FO
SFAT
O M
ON
OID
RATO
/MET
FORM
INA
CLO
RIDR
ATO
03
8678
102
VELM
ETIA
56
cpr
riv
50 m
g +
1.00
0 m
g M
ERCK
SHA
RP &
DO
HME
BV
A 62
,34
x
N01
BB02
LI
DOCA
INA
0403
3502
2 VE
RSAT
IS
10 c
erot
ti m
edic
ati 7
00 m
g G
RUN
ENTH
AL IT
ALIA
Srl
A
36,1
0
x
N01
BB02
LI
DOCA
INA
0403
3505
9 VE
RSAT
IS
30 c
erot
ti m
edic
ati 7
00 m
g G
RUN
ENTH
AL IT
ALIA
Srl
A
108,
30
x
A10B
J02
LIRA
GLU
TIDE
03
9365
010
VICT
OZA
2
penn
e pr
erie
mpi
te S
C 3
ml 6
mg/
ml
NO
VO N
ORD
ISK
A/S
A
138,
76
x
N03
AX18
LA
COSA
MID
E 03
8919
015
VIM
PAT
14 c
pr ri
v 50
mg
UCB
PHA
RMA
S.A.
A 12
,56
x
N03
AX18
LA
COSA
MID
E 03
8919
027
VIM
PAT
56 c
pr ri
v 50
mg
UCB
PHA
RMA
S.A.
A 50
,24
x
N03
AX18
LA
COSA
MID
E 03
8919
041
VIM
PAT
14 c
pr ri
v 10
0 m
g U
CB P
HARM
A S.
A.
A
25,1
2
x
N03
AX18
LA
COSA
MID
E 03
8919
054
VIM
PAT
56 c
pr ri
v 10
0 m
g U
CB P
HARM
A S.
A.
A
100,
47
x
N03
AX18
LA
COSA
MID
E 03
8919
078
VIM
PAT
14 c
pr ri
v 15
0 m
g U
CB P
HARM
A S.
A.
A
37,7
0
x
N03
AX18
LA
COSA
MID
E 03
8919
080
VIM
PAT
56 c
pr ri
v 15
0 m
g U
CB P
HARM
A S.
A.
A
150,
71
x
N03
AX18
LA
COSA
MID
E 03
8919
116
VIM
PAT
56 c
pr ri
v 20
0 m
g U
CB P
HARM
A S.
A.
A
200,
95
x
— 34 —
GAZZETTA UFFICIALE DELLA REPUBBLICA ITALIANA Serie generale - n. 30227-12-2019
ATC
Prin
cipi
o At
tivo
AIC
Den
omin
azio
ne
Conf
ezio
ne
Tito
lare
AIC
Cl
asse
Pr
ezzo
(€)
PB5
%
2019
N06
AX12
BU
PRO
PIO
NE
CLO
RIDR
ATO
03
7685
056
WEL
LBU
TRIN
30
cpr
300
mg
rilas
cio
mod
ifica
to fl
acon
e G
LAXO
SMIT
HKLI
NE
SpA
A 41
,04
x
N04
BD03
SA
FIN
AMID
E M
ETAN
SOLF
ON
ATO
04
3906
039
XADA
GO
30
cpr
riv
50 m
g ZA
MBO
N S
pA
A 13
7,58
x
N04
BD03
SA
FIN
AMID
E M
ETAN
SOLF
ON
ATO
04
3906
080
XADA
GO
30
cpr
riv
100
mg
ZAM
BON
SpA
A
137,
58
x
S01E
E01
LATA
NO
PRO
ST
0386
1103
6 XA
LIBU
R co
llirio
30
mon
od 0
,2 m
l 0,0
05%
PF
IZER
ITAL
IA S
rl
A 9,
84
x
A10B
H01
SI
TAG
LIPT
IN F
OSF
ATO
MO
NO
IDRA
TO
0377
9402
9 XE
LEVI
A 28
cpr
riv
25 m
g M
ERCK
SHA
RP &
DO
HME
BV
A 62
,34
x
A10B
H01
SI
TAG
LIPT
IN F
OSF
ATO
MO
NO
IDRA
TO
0377
9408
2 XE
LEVI
A 28
cpr
riv
50 m
g M
ERCK
SHA
RP &
DO
HME
BV
A 62
,34
x
A10B
H01
SI
TAG
LIPT
IN F
OSF
ATO
MO
NO
IDRA
TO
0377
9414
4 XE
LEVI
A 28
cpr
riv
100
mg
MER
CK S
HARP
& D
OHM
E BV
A
62,3
4
x
N07
XX06
TE
TRAB
ENAZ
INA
0366
8801
2 XE
NAZ
INA
112
cpr d
iv 2
5 m
g PH
ARM
ASW
ISS
CESK
A RE
PUBL
.S.R
.O
A 15
3,19
A10B
D15
DAPA
GLI
FLO
ZIN
PRO
PAN
EDIO
LO M
ON
OID
RATO
/MET
FORM
INA
CLO
RIDR
ATO
04
3208
038
XIG
DUO
56
cpr
riv
5 m
g +
850
mg
ASTR
AZEN
ECA
AB
A
56,1
0
x
A10B
D15
DAPA
GLI
FLO
ZIN
PRO
PAN
EDIO
LO M
ON
OID
RATO
/MET
FORM
INA
CLO
RIDR
ATO
04
3208
091
XIG
DUO
56
cpr
riv
5 m
g +
1.00
0 m
g AS
TRAZ
ENEC
A AB
A 56
,10
x
V10X
X03
RADI
O-2
23RA
-DIC
LORU
RO
0431
1601
9 XO
FIG
O
1 fla
conc
ino
EV 6
ml 1
.100
kbq
/ml
BAYE
R AG
H 4.
180,
00
x
R03A
L04
INDA
CATE
ROLO
MAL
EATO
/GLI
COPI
RRO
NIO
BRO
MU
RO
0430
3303
6 XO
TERN
A BR
EEZH
ALER
po
lv in
al 3
0x1
cps
85 m
cg +
43
mcg
N
OVA
RTIS
EU
ROPH
ARM
LTD
A
63
,50
x
A10A
E56
INSU
LIN
A D
EGLU
DEC/
LIRA
GLU
TIDE
04
3619
030
XULT
OPH
Y 5
penn
e pr
erie
mp
SC 3
ml 1
00 U
/ml +
3,6
mg/
ml
NO
VO N
ORD
ISK
A/S
A
352,
43
x
J05A
B15
BRIV
UDI
NA
0357
2201
4 ZE
COVI
R 7
cpr 1
25 m
g LA
BORA
TORI
GU
IDO
TTI S
pA
A 95
,93
x
M04
AB05
LE
SIN
URA
D 04
4727
030
ZURA
MPI
C 30
cpr
riv
200
mg
GRU
NEN
THAL
Gm
bH
A
40,3
8
x
D06B
B10
IMIQ
UIM
OD
0435
8502
5 ZY
CLAR
A cr
ema
derm
28
bust
250
mg
3,75
%
MED
A A.
B.
A
96,1
0
x
19A08049
